1.Inhibitory Effect of Pyra-Metho-Carnil on the Differentiation and Maturation of Macrophages in Normal and Cancer Microenvironments.

Kitaguchi T, Matsumoto T, Yoshida K, Hamaguchi Y, Maruta G, Maeoka H, Ishikura S, Nakano M, Ishida Y, Hirai F, Aoki M, Kodama S, Shirasawa S, Tsunoda T.

ANTICANCER RESEARCH International Journal of Cancer Research and Treatment 44(8):3557-3565,2024

2.Tranilast Inhibits TRPV2 and Suppresses Fibrosis Progression and Weight Gain in a NASH Model Mouse.

Nagata T, Shakado S, Yamauchi E, Tokushige H, Miyayama T, Yamauchi R, Fukuda H, Fukunaga A, Tanaka T, Takata K,Yokoyama K, Hirai F.

ANTICANCER RESEARCH International Journal of Cancer Research and Treatment 44(8):3593-3604,2024

3.Association of blood group O with a recurrent risk for acute lower gastrointestinal bleeding from a multicenter cohort study.

Suzuki S, Tominaga N, Aoki T, Sadashima E, Miike T, Kawakami H, Kobayashi K, Yamauchi A, Yamada A, Omori J, Ikeya T, Aoyama T, Sato Y, Kishino T, Ishii N, Sawada T, Murata M, Takao A, Mizukami K, Kinjo K, Fujimori S, Uotani T, Fujita M, Sato H, Narasaka T, Hayasaka J, Funabiki T, Kinjo Y, Mizuki A, Kiyotoki S, Mikami T, Gushima R, Fujii H, Fuyuno Y, Hikichi T, Toya Y, Narimatsu K, Manabe N, Nagaike K, Kinjo T, Sumida Y, Funakoshi S, Kobayashi K, Matsuhashi T, Komaki Y, Kaise M, Nagata N.

Scientific Reports 14(1):13983,2024

4.Radial force and wire structure determine the onset of covered self-expandable metal stent migration in endoscopic ultrasound-guided hepaticogastrostomy: Measurement of sliding-resistance force using a porcine model

Koga T, Yamada H, Ishida Y, Tsuchiya N, Kitaguchi T, Matsumoto K, Fukuyama M, Kojima N, Hirai F

J Hepatobiliary Pancreat Sci 31(11):840-849-,2024

5.Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials

Louis E, Schreiber S, Panaccione R, Bossuyt P, Biedermann L,Colombel JF, Parkes G, Peyrin-Biroulet L, D’Haens G, Hisamatsu T, Siegmund B, Wu K, Boland BS, Melmed GY,Armuzzi A, Levine P, Kalabic J, Chen S, Cheng L, Shu L,Duan WR, Pivorunas V, Sanchez Gonzalez Y, D’Cunha R, Neimark E, Wallace K, Atreya R, Ferrante M,Loftus EV Jr; INSPIRE and COMMAND Study Group.

Journal of American Medical Association 332(11):881-897,2024

6.Efficacy and safety of mirikizumab as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a subgroup analysis of the global phase 3 LUCENT-1 and LUCENT-2 studies.

Kobayashi T, Matsuoka K, Watanabe M, Hisamatsu T, Hirai F, Milata J, Li X, Morris N, Arora V, Ishizuka T, Matsuo K,Satoi Y, Milch C, Hibi T.

Intestinal research 22(2):172-185,2024

7.Structural factors influencing the clinical performance of 0.025-inch guidewires for pancreatobiliary endoscopy: An experimental study.

Koga T, Tsuchiya N, Ishida Y, Kitaguchi T, Matsumoto K, Fukuyama M, Kojima S, Kojima N, Hirai F.

Endoscopy International Open 12(5):E666-E675,2024

8.Impact of twice-daily budesonide foam administration on early clinical response and endoscopic remission in patients with ulcerative colitis: a post hoc analysis.

Watanabe K, Hirai F, Kobayashi K, Takeuchi K, Kurosu S, Inagaki K, Iwayama KI, Naganuma M.

Journal of Gastroenterology and Hepatology 39(11):2367-2376,2024

9.Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn’s disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study

Ferrante M, D’Haens G, Jairath V, Danese S, Chen M, Ghosh S, Hisamatsu T, Kierkus J, Siegmund B, Bragg SM,Crandall W, Durand F, Hon E, Lin Z, Lopes MU, Morris N, Protic M, Carlier H, Sands BE; VIVID Study Group.

Lancet 404(10470)2423-2436,2024

10.Feasibility and safety of EUS-guided biliary drainage in inexperienced centers: a multicenter study in southwest Japan

Koga T, Ishida Y, Hashigo S, Shimokawa Y, Harima H, Okamoto K, Ohno A, Miyagahara T, Fujita T, Fukuchi S,Takahashi K, Taguchi H, Araki N, Ohtsuka Y, Uekitani T, Tsuneyoshi K, Akiyama T, Ishigaki N, Maruo T, Saito H, Ihara R, Yamasuji A, Oe S, Yoshinari M, Sagami R, Fujimori N, Fukuda Y, Ozawa E, Jikuya K, Shinohara H, Sen-Yo M, Ueki T, Tsuchiya N, Kitaguchi T, Matsumoto K, Fukuyama M, Hirai F.

Gastrointestinal Endoscopy S0016-5107(24)03495-3,2024

11.Involvement of Mediterranean fever gene mutations in colchicine-responsive enterocolitis: a retrospective cohort study

Nakase H, Wagatsuma K, Kobayashi T, Matsumoto T, Esaki M, Watanabe K, Kunisaki R, Takeda T, Arai K, Ibuka T, Ishikawa D,Matsuno Y, Sakuraba H, Ueno N, Yokoyama K, Saruta M, Hokari R, Yokoyama J, Tamano S, Nojima M, Hisamatsu T; MEFV-IBDU Group.

EBioMedicine doi: 10.1016/j.ebiom.2024.105454

12.炎症性腸疾患内視鏡診療ガイドライン

松本主之、 久松理一、 江崎幹宏、 大森鉄平、 櫻庭裕丈、新崎信一郎、 杉本 健、 竹中健人、 長沼 誠、 馬場重樹、久部高司、 平岡佐規子、藤谷幹浩、松浦 稔、 梁井俊一、 渡辺憲治、 緒方晴彦、 安藤 朗、 仲瀬裕志、 大塚和朗、平井郁仁、 藤城光弘、 五十嵐良典、 田中信治、 日本消化器内視鏡学会、 厚生労働科学研究費補助金難治性疾患政策研究事業難治性炎症性腸管障害に関する調査研究(久松班)

Gastroenterological Endoscopy 66(6):1387-1426,2024

13.High risk stigmata and treatment strategy for acute lower gastrointestinal bleeding: a nationwide study in Japan.

Aoki T, Sadashima E, Kobayashi K, Yamauchi A, Yamada A, Omori J, Ikeya T, Aoyama T, Tominaga N, Sato Y, Kishino T, Ishii N, Sawada T, Murata M, Takao A, Mizukami K, Kinjo K, Fujimori S, Uotani T, Fujita M, Sato H, Hayakawa Y, Fujishiro M, Kaise M, Nagata N; CODE BLUE-J Study collaborators.

Endoscopy 56(4):291-301,2024

14.Validation of British Society of Gastroenterology guidelines for acute lower GI bleeding from 8956 cases in Japan.

Kinjo K, Aoki T, Kobayashi K, Yamauchi A, Yamada A, Omori J, Ikeya T, Aoyama T, Tominaga N, Sato Y, Kishino T, Ishii N, Sawada T, Murata M, Takao A, Mizukami K, Fujimori S, Uotani T, Fujita M, Sato H, Suzuki S, Narasaka T, Hayasaka J, Funabiki T, Kinjo Y, Mizuki A, Kiyotoki S, Mikami T, Gushima R, Fujii H, Fuyuno Y, Hikichi T, Toya Y, Narimatsu K, Manabe N, Nagaike K, Kinjo T, Sumida Y, Funakoshi S, Kobayashi K, Matsuhashi T, Komaki Y, Watanabe K, Hisabe T, Yao K, Kaise M, Nagata N.

Gastrointestinal Endoscopy doi:10.1016/j.gie.2024.11.020

15.Clinical performance of endoscopic ultrasound-guided tissue acquisition for perivascular soft-tissue cuffing suspected to be extravascular migratory metastases of pancreatic or bile duct cancer (with video)

Maehara K, Hijioka S, Nagashio Y, Maruki Y, Yamashige D, Okamoto K, Agarie D, Yagi S, Fukuda S, Kuwada M, Komori Y, Koga T, Kanno A, Imamura T, Saito Y, Okusaka T

Digestive Endoscopy 2024 Dec 26. doi: 10.1111/den.14983. Online ahead of print.

16.Guidelines for endoscopic diagnosis and treatment of inflammatory bowel diseases.

Matsumoto T, Hisamatsu T, Esaki M, Omori T, Sakuraba H, Shinzaki S, Sugimoto K, Takenaka K, Naganuma M, Bamba S, Hisabe T, Hiraoka S, Fujiya M, Matsuura M, Yanai S, Watanabe K, Ogata H, Andoh A, Nakase H, Ohtsuka K, Hirai F, Fujishiro M, Igarashi Y, Tanaka S.

Digestive Endoscopy doi: 10.1111/den.15002. Online ahead of print.

17.Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies.

Rubin DT, Allegretti JR, Panés J, Shipitofsky N, Yarandi SS, Huang KG, Germinaro M, Wilson R, Zhang H, Johanns J, Feagan BG, Hisamatsu T, Lichtenstein GR, Bressler B, Peyrin-Biroulet L, Sands BE, Dignass A; QUASAR Study Group.

Lancet 405(10472):33-49,2025

18.Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study.

Okabe M, Yamamoto S, Shiokawa M, Hisamatsu T, Yamazaki H, Nakanishi R, Hamada K, Kitamoto H, Kuwada T, Uza N, Sakatani A, Fujii T, Ohno M, Matsuura M, Shibuya T, Ohmiya N, Ooi M, Hoshi N, Moriya K, Tsuchiya K, Yamaguchi Y, Kunisaki R, Takahara M, Takagi T, Takehara T, Hirai F, Kakimoto K, Esaki M, Nakase H, Kinjo F, Torisu T, Kanmura S, Narimatsu K, Matsuoka K, Hiraga H, Yokoyama K, Honzawa Y, Naganuma M, Saruta M, Kodama Y, Chiba T, Seno H.

Journal of Gastroenterology 60(1):86-95,2025

19.Outcome and Prognosis of Invasive Treatment for Hepatocellular Carcinoma in Very Elderly Patients Over 90 Years Old.

Yokoyama K, Tokushige H, Nagata T, Miyayama T, Shibata K, Fukuda H, Yamauchi R, Fukunaga A, Takata K, Tanaka T, Shakado S, Sakisaka S, Hirai F.

Turkish Journal of Gastroenterology 13,36(6):381-389,2025

20.Diagnostic accuracy and cut-off values of serum leucine-rich alpha-2 glycoprotein for Crohn’s disease activity in the small bowel.

Okita M, Takenaka K, Hirai F, Ashizuka S, Iijima H, Bamba S, Fujii T, Watanabe K, Shimodaira Y, Shiga H, Hiraoka S,Inokuchi T, Yamamura T, Emoto R, Matsui S.

Journal of Gastroenterology doi:10.1007/s00535-025-02223-1. Online ahead of print.

1.Disappearance of Hepatocellular Adenoma in a Patient with Cornelia de Lange Syndrome after Treatment with Transcatheter Arterial Embolization.

Takata K, Kitaguchi T, Tokushige H, Nagata T, Miyayama T, Shibata K, Fukuda H,Yamauchi R, Fukunaga A, Tanaka T, Yokoyama K, Shakado S, Yoshimitsu K,Kusano H, Sakisaka S, Hirai F.

Internal Medicine 63(11):1569-1573,2024

2.Two cases of severe oral mucositis caused by atezolizumab plus bevacizumab combination therapy for hepatocellular carcinoma.

Shimoji Y, Yamauchi R, Shibata K, Fukuda H, Fukunaga A, Tanaka T, Takata K, Yokoyama K, Shakado S, Hirai F.

Clinical Journal of Gastroenterology 17(3):523-529,2024

3.胃静脈瘤　Case Study　直視型超音波内視鏡を用いて内視鏡的組織接着剤注入法を施行した胃静脈瘤の1例

横山圭二、宮山隆志、 山内 涼,、釈迦堂敏、平井郁仁

消化器内視鏡 36(12):1694-1696,2024

4.Emphysematous Gastritis with Hepatic Portal Venous Gas.

Takata K, Maeda T, Kuno N, Hirai F

Internal Medicine 64(5):797-798,2025

1.小腸・大腸 Crohn病 病型分類

久能宣昭、平井郁仁

胃と腸　増大号 消化管疾患の分類2024 59(4):575,2024

2.小腸・大腸 Crohn病 モントリオール分類

松岡弘樹、平井郁仁

胃と腸　増大号 消化管疾患の分類2024 59(4):576-577,2024

3.クローン病診療の最前線と課題－疫学から治療まで－

平井郁仁、芦塚伸也、久能宣昭

日本消化器病 学会雑誌 121(7):523-534,2024

4.肝門部胆管狭窄の診断ストラテジー

石田祐介、土屋直壮、古賀毅彦、松元慶亮、福山　真、平井郁仁

臨牀消化器内科 39(13):1601-1610,2024

5.主題 炎症性腸疾患の長期経過　Crohn病の長期予後

今給黎 宗、芦塚伸也、犬尾和子、柯 懿玲、木村俊大、黒木大世、能丸遼平、松岡弘樹、久能宣昭、船越禎広、塩川桂一、長谷川 傑、平井郁仁

胃と腸 59(10):1531-1542,2024

6.【大腸の炎症を内視鏡で診る】総論 大腸の炎症性疾患の診断アルゴリズム

平井郁仁 、黒木大世、芦塚伸也

消化器内視鏡 36(11):1491-1498,2024

7.総論 6.循環動態を含む全身管理（術前・術中・術後）

平井郁仁、船越禎広、岡政志

消化器内視鏡ハンドブック 改訂 第3版 60-68,2024

1.Treatment Patterns in Newly Diagnosed Patients with Crohn’s Disease Who Received Biologics Following Diagnosis: A Nationwide, Retrospective, Longitudinal, Observational Study Using a Medical Claims Database in Japan

Hirai F, Uda A, Ota M, Takemura Y, Tanaka K, Iwakiri R.

Digestion104 (2): 109–120,2023

2.Nationwide cohort study identifies clinical outcomes of angioectasia in patients with acute hematochezia

Kobayashi M, Akiyama S, Narasaka T, Kobayashi K, Yamauchi A, Yamada A, Omori J, Ikeya T, Aoyama T, Tominaga N, Sato Y, Kishino T, Ishii N, Sawada T, Murata M, Takao A, Mizukami K, Kinjo K, Fujimori S, Uotani T, Fujita M, Sato H, Suzuki S, Hayasaka J, Funabiki T, Kinjo Y, Mizuki A, Kiyotoki S, Mikami T, Gushima R, Fujii H, Fuyuno Y, Gunji N, Toya Y, Narimatsu K, Manabe N, Nagaike K, Kinjo T, Sumida Y, Funakoshi S, Kobayashi K, Matsuhashi T, Komaki Y, Miki K, Watanabe K, Tsuchiya K, Kaise M, Nagata N.

Journal of Gastroenterology58(4):367-378,2023

3.Machine learning-based model for prediction and feature analysis of recurrence in pancreatic neuroendocrine tumors G1/G2

Murakami M, Fujimori N, Nakata K, Nakamura M, Hashimoto S, Kurahara H, Nishihara K, Abe T, Hashigo S, Kugiyama N, Ozawa E, Okamoto K, Ishida Y, Okano K, Takaki R, Shimamatsu Y, Ito T, Miki M, Oza N, Yamaguchi D, Yamamoto H, Takedomi H, Kawabe K, Akashi T, Miyahara K, Ohuchida J, Ogura Y, Nakashima Y, Ueki T, Ishigami K, Umakoshi H, Ueda K, Oono T, Ogawa Y

Journal of Gastroenterology58:586-597,2023

4.Prospective clinical trial of EUS-guided choledochoduodenostomy without fistula dilation for malignant distal biliary obstruction

Koga T, Hijioka S, Nagashio Y, Maruki Y, Maehara K, Murashima Y, Kawasaki Y, Takeshita K, Yamada N, Yoshinari M, Hisada Y, Harai S, Kitamura H, Kawahara S, Ohba A, Morizane C, Ishida Y, Hirai F, Okusaka T.

Endoscopic Ultrasound12(5):409-416,2023

5.Malnutrition and inflammation status in nonobese patients with inflammatory bowel disease are associated with nonalcoholic fatty liver disease: a retrospective study

Nagata T, Funakoshi S, Morihara D, Shakado S, Yokoyama K, Takata K, Tanaka T, Fukunaga A, Yamauchi R, Fukuda H, Matsuoka H, Imakiire S, Sakisaka H, Matsuoka S, Kuno N, Abe K, Ishibashi H, Ashizuka S, Hirai F

Intestinal research21(4):471-480,2023

6.A new endoscopic scoring system corresponding to histological healing using linked color imaging in ulcerative colitis: the SOUL study

Saito D, Hirai F, Uchiyama K, Takagi T, Naito Y, Takatsu N, Tanabe H, Kishimoto M, Matsuura M, Miyoshi J, Watanabe K, Esaki M, Naganuma M, Hisamatsu T

Endoscopy International Open11(5):E504-E512,2023

7.Long-term outcome and eligibility of radiofrequency ablation for hepatocellular carcinoma over 3.0 cm in diameter

Tanaka T, Takata K, Miyayama T, Shibata K, Fukuda H, Yamauchi R, Fukunaga A, Yokoyama K, Shakado S, Sakisaka S, Hirai F

Scientific Reports13(1):16286. doi: 10.1038/s41598-023-43516-w.

8.Trajectory analyses to identify persistently low responders to COVID-19 vaccination in patients with inflammatory bowel disease: a prospective multicentre controlled study, J-COMBAT

Watanabe K, Nojima M, Nakase H, Sato T, Matsuura M, Aoyama N, Taku Kobayashi T, Sakuraba H, Nishishita M, Yokoyama K, Esaki M, Hirai F, Nagahori M, Nanjo S, Omori T, Tanida S, Yokoyama Y, Moriya K, Maemoto A, Handa O, Ohmiya N, Tsuchiya K, Shinzaki S, Kato S, Uraoka T, Tanaka H, Takatsu N, Nishida A, Umeno J, Nakamura M, Mishima Y, Fujiya M, Tsuchida K, Hiraoka S, Okabe M, Toyonaga T, Matsuoka K, Andoh A, Yoshio Hirota Y, Hisamatsu T; J-COMBAT study group

Journal of Gastroenterology58(10):1015-1029.,2023

9.Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis

Geert D’Haens, Marla Dubinsky, Kobayashi T, Peter M Irving, Stefanie Howaldt , Juris Pokrotnieks, Kathryn Krueger, Janelle Laskowski, Xingyuan Li, Trevor Lissoos, Joe Milata, Nathan Morris, Vipin Arora, Catherine Milch, William Sandborn, Bruce E Sands; LUCENT Study Group

The New England Journal of Medicine388(26):2444-2455,2023

10.Development and validation of a novel model for predicting stigmata of recent hemorrhage in acute lower gastrointestinal bleeding: Multicenter nationwide study

Aoki T, Yamada A, Kobayashi K, Yamauchi A, Omori J, Ikeya T, Aoyama T, Tominaga N, Sato Y, Kishino T, Ishii N, Sawada T, Murata M, Takao A, Mizukami K, Kinjo K, Fujimori S, Uotani T, Fujita M, Sato H, Suzuki S, Narasaka T, Hayasaka J, Funabiki T, Kinjo Y, Mizuki A, Fujishiro M, Kaise M, Nagata N; Collaborators.

Digestive Endoscopy35(6):777-789,2023

11.Multicenter propensity score-matched analysis comparing short versus long cap-assisted colonoscopy for acute hematochezia

Kobayashi M, Akiyama S, Narasaka T, Kobayashi K, Yamauchi A, Yamada A, Omori J, Ikeya T, Aoyama T, Naoyuki Tominaga N, Sato Y, Takaaki Kishino T, Ishii N, Sawada T, Murata M, Takao A, Mizukami K, Kinjo K, Fujimori S, Uotani T, Fujita M, Sato H, Suzuki S, Hayasaka J, Funabiki T, Kinjo Y, Mizuki A, Kiyotoki S, Mikami T, Gushima R, Fujii H, Fuyuno Y, Gunji N, Toya Y, Narimatsu K, Manabe N, Nagaike K, Kinjo T, Sumida Y, Funakoshi S, Kobayashi K, Matsuhashi T, Komaki Y, Tsuchiya K, Kaise M, Nagata N

An open access journal of Gastroenterology and Hepatology7(7):487-496,2023

12.Early feeding reduces length of hospital stay in patients with acute lower gastrointestinal bleeding: A large multicentre cohort study

Kishino T, Aoki T, Sadashima E, Kobayashi K, Yamauchi A, Yamada A, Omori J, Ikeya T, Aoyama T, Tominaga N, Sato Y, Ishii N, Sawada T, Murata M, Takao A, Mizukami K, Kinjo K, Fujimori S, Uotani T 18, Fujita M, Sato H, Suzuki S, Narasaka T, Hayasaka J, Funabiki T, Kinjo Y, Mizuki A, Kiyotoki S, Mikami T, Gushima R, Fujii H, Fuyuno Y, Gunji N, Toya Y, Narimatsu K, Manabe N, Nagaike K, Kinjo T, Sumida Y, Funakoshi S, Kobayashi K, Matsuhashi T, Komaki Y, Kaise M, Nagata N

International journal of colorectal disease25(11):2206-2216,2023

13.LONG-HOSP Score: A Novel Predictive Score for Length of Hospital Stay in Acute Lower Gastrointestinal Bleeding – A Multicenter Nationwide Study

Fujita M, Aoki T, Manabe N, Ito Y, Kobayashi K, Yamauchi A, Yamada A, Omori J, Ikeya T, Aoyama T, Tominaga N, Sato Y, Kishino T, Ishii N, Sawada T, Murata M, Takao A, Mizukami K, Kinjo K, Fujimori S, Uotani T, Sato H, Suzuki S, Narasaka T, Hayasaka J, Funabiki T, Kinjo Y, Mizuki A, Kiyotoki S, Mikami T, Gushima R, Fujii H, Fuyuno Y, Gunji N, Toya Y, Narimatsu K, Nagaike K, Kinjo T, Sumida Y, Funakoshi S, Kobayashi K, Matsuhashi T, Komaki Y, Miki K, Watanabe K, Ayaki M, Murao T, Suehiro M, Shiotani A, Hata J, Haruma K, Kaise M, Nagata N.

Digestion104(6):446-459,2023

14.Weekend Effect on Clinical Outcomes of Acute Lower Gastrointestinal Bleeding: A Large Multicenter Cohort Study in Japan

Hayasaka J, Kikuchi D, Ishii N, Kobayashi K, Yamauchi A, Yamada A, Omori J, Ikeya T, Aoyama T, Tominaga N, Sato Y, Kishino T, Sawada T, Murata M, Takao A, Mizukami K, Kinjo K, Fujimori S, Uotani T, Fujita M, Sato H, Suzuki S, Narasaka T, Funabiki T, Kinjo Y, Mizuki A, Kiyotoki S, Mikami T, Gushima R, Fujii H, Fuyuno Y, Gunji N, Toya Y, Narimatsu K, Manabe N, Nagaike K, Kinjo T, Sumida Y, Funakoshi S, Kobayashi K, Matsuhashi T, Komaki Y, Miki K, Watanabe K, Odagiri H, Hoteya S, Kaise M, Nagata N.

Digestion104(6):446-459,2023

15.Outcomes and recurrent bleeding risks of detachable snare and band ligation for colonic diverticular bleeding: a multicenter retrospective cohort study

Yamauchi A, Ishii N, Yamada A, Kobayashi K, Omori J, Ikeya T, Aoyama T, Tominaga N, Sato Y, Kishino T, Sawada T, Murata M, Takao A, Mizukami K, Kinjo K, Fujimori S, Uotani T, Fujita M, Sato H, Suzuki S, Narasaka T, Hayasaka J, Funabiki T, Kinjo Y, Mizuki A, Kiyotoki S, Mikami T, Gushima R, Fujii H, Fuyuno Y, Gunji N, Toya Y, Narimatsu K, Manabe N, Nagaike K, Kinjo T, Sumida Y, Funakoshi S, Kobayashi K, Matsuhashi T, Komaki Y, Miki K, Watanabe K, Mori Y, Osawa K, Nakagami S, Kawai Y, Yoshikawa T, Kaise M, Nagata N.

Gastrointestinal Endoscopy98(1):59-72,2023

16.Long-term Risks of Recurrence After Hospital Discharge for Acute Lower Gastrointestinal Bleeding: A Large Nationwide Cohort Study

Sato Y, Aoki T, Sadashima E, Nakamoto Y, Kobayashi K, Yamauchi A, Yamada A, Omori J, Ikeya T, Aoyama T, Tominaga N, Kishino T, Ishii N, Sawada T, Murata M, Takao A, Mizukami K, Kinjo K, Fujimori S, Uotani T, Fujita M, Sato H, Suzuki S, Narasaka T, Hayasaka J, Funabiki T, Kinjo Y, Mizuki A, Kiyotoki S, Mikami T, Gushima R, Fujii H, Fuyuno Y, Gunji N, Toya Y, Narimatsu K, Manabe N, Nagaike K, Kinjo T, Sumida Y, Funakoshi S, Kobayashi K, Matsuhashi T, Komaki Y, Maehata T, Tateishi K, Kaise M, Nagata N.

Clinical Gastroenterology and Hepatology21(13):3258-3269,2023

17.Comparison of 6-mm and 10-mm-diameter, fully-covered, self-expandable metallic stents for distal malignant biliary obstruction

Harai S, Hijioka S, Nagashio Y, Ohba A, Maruki Y, Yamashige D, Hisada Y, Yoshinari M, Kitamura H, Maehara K, Murashima Y, Kawasaki Y, Koga T, Takeshita K, Ueno H, Kondo S, Morizane C, Fukasawa M, Sone M, Saito Y, Enomoto N, Okusaka T

Endosc Int Open11(04): E340-E348,2023

“

18.Usefulness of a laser-cut covered metal stent with a 7F delivery sheath in endoscopic ultrasound-guided biliary drainage without fistula dilation.

Takeshita K, Hijioka S, Nagashio Y, Maruki Y, Ohba A, Kawasaki Y, Hisada Y, Yoshinari M, Harai S, Kitamura H, Koga T, Maehara K, Murashima Y, Yamada N, Okada M, Takasaki T, Agarie D, Hara H, Hagiwara Y, Okamoto K, Yamashige D, Kondo S, Morizane C, Ueno H, Saito Y, Okusaka T

Endosc Int Open.2023 Jan 26;11(1):E97-E104. doi: 10.1055/a-1997-9149. eCollection 2023 Jan. PMID: 36712906

“

19.Nationwide multicenter study on adverse events associated with a patency capsule: Additional survey of appropriate use of patency capsule study

Omori T , Ohmiya N, Watanabe K, Hirai F, Nakamura M, Kitamura K, Ozeki K, Oka S, Kawano S, Handa O, Kawai M, Ninomiya K, Sagawa T, Wakamatsu T, Araki A, Koike Y, Kato S, Hashimoto S, Mannami T, Nakaji K, Tanaka S, Matsui T ; J-POP study group

Journal of Gastroenterology and Hepatology39(2):337-345,2024

20.Efficacy and safety of 48 weeks of guselkumab for patients with Crohn’s disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial

Silvio Danese, Remo Panaccione, Brian G Feagan, Anita Afzali, David T Rubin, Bruce E Sands, Walter Reinisch, Julián Panés, Aparna Sahoo, Natalie A Terry, Daphne Chan, Chenglong Han, Mary Ellen Frustaci, Zijiang Yang, William J Sandborn, Hisamatsu T, Jane M Andrews, Geert R D’Haens; GALAXI-1 Study Group

The Lancet Gastroenterology & Hepatology9(2):133-146,2024

21.Safety of biliary drainage with 6-mm metallic stent for preoperative obstructive jaundice in pancreatic cancer: PURPLE SIX STUDY

Harai S, Hijioka S, Yamada R, Ogura T, Fukasawa M, Okuda A, Horike H, Inoue D, Sekine M, Ishida Y, Koga T, Kitamura H, Tanaka Y, Yoshinari M, Kobayashi K, Chatto M, Yamashige D, Kawasaki Y, Nagashio Y, Okusaka T

J Gastroenterol Hepatol2024 Feb 29. doi: 10.1111/jgh.16524. Online ahead of print.

22.胃胆管瘻孔形成術⽤ステントのメッシュ形状が胃壁からの引抜き⼒に及ぼす影響に関する有限要素解析

⻄祐次朗、⼭⽥　宏、古賀毅彦

日本機械学会九州支部第76期総会・講演会講演論文集

1.Resolution of Laryngeal Ulceration with Prednisolone Therapy in a Patient with Crohn’s Disease

Ko YL, Matsuoka H, Nomaru R, Imakiire S, Sakisaka H, Matsuoka S, Kuno N, Abe K, Funakoshi S, Ishida Y, Ishibashi H, Miyagi S, Sakata T, Hirai F.

Internal Medicine62(14):2071-2075, 2023

2.Complete tumor necrosis confirmed by conversion hepatectomy after atezolizumab–bevacizumab treatment for advanced-stage hepatocellular carcinoma with lung metastasis

Fukunaga A, Takata K, Itoh S, Yamauchi R, Tanaka T, Yokoyama K, Shakado S, Kohashi K, Yoshizumi T & Hirai F

Clinical Journal of Gastroenterology16(2):224-228.2023

3.Successful removal of a migrated biliary plastic stent using a novel spiral dilator

Ishida Y, Koga T, Tsuchiya N, Hata K, Nishioka K, Shiga N, Hirai F

Endoscopy 55(S 01): E804-E805, 2023

4.Disappearance of Hepatocellular Adenoma in a Patient with Cornelia de Lange Syndrome after Treatment with Transcatheter Arterial Embolization

Takata K, Kitaguchi T, Tokushige H, Nagata T, Miyayama T, Shibata K, Fukuda H, Yamauchi R, Fukunaga A, Tanaka T, Yokoyama K, Shakado S, Yoshimitsu K, Kusano H, Sakisaka S, Hirai F

Internal Medicinedoi:10.2169/internalmedicine.2537-23

5.Preoperatively diagnosed intraductal oncocytic papillary neoplasm of the pancreas with prominent invasion: a case report

Nomaru R, Ishida Y, Kitaguchi T, Koga T, Tsuchiya N, Nakashima R, Sato K, Hamada Y, Hasegawa S, Hirai F

Clinical Journal of Gastroenterology16(5):772-778,2023

6.A Case of L-Asparaginase-Induced Severe Hepatic Steatosis With Decreased Serum Cholinesterase Levels

Takata K, Nakashima Y, Shakado S, Takamatsu Y, Hirai F

Cureus 15(12):e49787. doi:10.7759/cureus.49787.

7.Hepatitis C Virus-associated Cryoglobulinemic Livedo Reticularis Improved with Direct-acting Antivirals

Yokoyama K, Kino T, Nagata T, Miyayama T, Shibata K, Fukuda H, Yamauchi R, Fukunaga A, Umeda K, Takata K, Tanaka T, Shakado S, Sakisaka S, Imafuku S, Hirai F

Internal Medicine62(24):3631-3636,2023

8.Endoscopic transpapillary repositioning of a migrated cystic duct tube using a gooseneck snare technique

Koga T, Ishida Y, Ishikawa H, Kishimoto Y, Kojima S, Okabe M, Hirai F

Endoscopy55(S01):E397-E399.2023

9.Novel hemostatic option using self-assembling peptide gel for endoscopic necrosectomy-related bleeding

Koga T, Ishida Y, Tsuchiya N, Kitaguchi T, Kurogi T, Shimoji Y, Hirai F

Endoscopy55(S01):E598-E599.2023

10.Minocycline-induced black hairy tongue and skin hyperpigmentation

Takata K, Hirai F

BMJ Case Rep.16(4):e253811. doi: 10.1136/bcr-2022-253811.

11.Amiodarone-induced hepatotoxicity

Nagata T, Takata K, Shakado S, Hirai F

BMJ Case Rep.16(11):e256679. doi: 10.1136/bcr-2023-256679.

12.Pigtail trap: Stent migration crisis following endoscopic ultrasound-guided gallbladder drainage

Koga T,Ishida Y, Hirai F

Digestive Endoscopy36(4):502-503,2024

13.Partial splenic embolization improved stomal varices in patient with decompensated liver cirrhosis: a case report

Yamauchi R, Takata K, Yokoyama K, Shibata K, Fukuda H, Fukunaga A, Tanaka T, Shakado S, Yoshimitsu K, Hirai F

Clinical Journal of Gastroenterology17(1):100-105,2024

14.治療抵抗性の潰瘍性大腸炎に上行大動脈内血栓と塞栓性脳梗塞を合併した 1 例

井上 賢一，緒方 利安，三嶋 崇靖，石橋 英樹，平井 郁仁，坪井 義夫

臨床神経学64（2）93-98,2023

1.【あなたの知らないIBD診療の世界】既存治療のupdate　バイオ製剤を用いない場合のクローン病の治療法　治療前評価の重要性,および栄養療法,ステロイド(ブデソニド含む),チオプリン製剤の活用法

久能宣昭、芦塚伸也、今給黎 宗、石橋英樹、船越禎広、平井 郁仁

臨牀消化器内科58(3):205-216,2023

2.IBD　診療現場のPros & Cons(No.9)(その1)　初発クローン病患者に対する小腸精査どちらを優先?　小腸造影or小腸造影以外　小腸造影の立場から

芦塚伸也、平井 郁仁

IBD Research17(1):56-60,2023

3.【「胃と腸」式 読影問題集2023 基本と応用-考える画像診断が身につく】小腸(Case 5)

石橋英樹、二村　聡、平井 郁仁

胃と腸58（4）：514-517,2023

4.【分類不能腸炎(IBDU)の現状と将来展望】非特異性多発性小腸潰瘍症診断における尿中プロスタグランジンE主要代謝産物(PGE-MUM)の有用性

松野雄一、梅野淳嗣、鳥巣剛弘、冬野雄太,、岡本康治、安川重義、平井郁仁、渡辺憲治、細江直樹、河内修司、蔵原晃一、八尾恒良、松本主之、江崎幹宏

胃と腸58（6）：773-781, 2023

5.治療法の再整理とアップデートのために専門家による私の治療　腸結核

平井郁仁、柴田　衛

日本医事新報5167：50-51, 2023

6.Treatment escalation and de-escalation decisions in Crohn’s disease: Delphi consensus recommendations from Japan, 2021

Nakase H, Esaki M, Hirai F, Kobayashi T, Matsuoka K, Minoru Matsuura M, Naganuma M, Saruta M, Tsuchiya K, Uchino M, Watanabe K, Hisamatsu T; TRADE consensus group

Journal of Gastroenterology58(4):313-345,2023

7.消化管T細胞リンパ腫の内視鏡所見の特徴

石橋 英樹, 二村 聡, 平井 郁仁, 竹下 盛重

胃と腸58(7):871-879,2023

1.Concomitant use of an immunomodulator with ustekinumab as an induction therapy for Crohn’s disease: A systematic review and meta-analysis.

Yoshihara T, Shinzaki S, Amano T, Iijima H, Takehara T, Inoue N, Uchino M, Esaki M, Kobayashi T, Saruta M, Sugimoto K, Nakamura S, Hata K, Hirai F, Hiraoka S, Fujii T, Matsuura M, Matsuoka K, Watanabe K, Nakase H, Watanabe M.

J Gastroenterol Hepatol.36（7）：1744-1753， 2021

2.Adrenomedullin for steroid-resistant ulcerative colitis: a randomized, double-blind, placebo-controlled phase-2a clinical trial.

Kita T, Ashizuka S, Ohmiya N, Yamamoto T, Kanai T, Motoya S, Hirai F, Nakase H, Moriyama T, Nakamura M, Suzuki Y, Kanmura S, Kobayashi T, Ohi H, Nozaki R, Mitsuyama K, Yamamoto S, Inatsu H, Watanabe K, Hibi T, Kitamura K.

J Gastroenterol.56(2):147-157, 2021

3.Novel ultrathin double-balloon endoscopy for the diagnosis ofsmall-bowel diseases: a multicenter nonrandomized study.

Nakamura M, Yano T, Esaki M, Oka S, Mitsui K, Hirai F, Kawasaki K, Fujishiro M, Torisu T, Tanaka S, Iwakiri K, Kishi M, Matsumoto T, Yamamoto H.

Endosc.53(8):802-814, 2021

4.Intestinal cancer in patients with Crohn’s disease: A systematic review and meta-analysis.

Uchino M, Ikeuchi H, Hata K, Minagawa T, Horio Y, Kuwahara R, Nakamura S, Watanabe K, Saruta M, Fujii T, Kobayashi T, Sugimoto K, Hirai F, Esaki M, Hiraoka S, Matsuoka K, Shinzaki S, Matsuura M, Inoue N, Nakase H, Watanabe M.

J Gastroenterol Hepatol.36（2）：329-336, 2021

5.Tag-less patency capsule for suspected small bowel stenosis: Nationwide multicenter prospective study in Japan.

Nakamura M, Watanabe K, Ohmiya N, Hirai F, Omori T, Tokuhara D, Nakaji K, Nouda S, Esaki M, Sameshima Y, Goto H, Terano A, Tajiri H, Matsui T, J-POP study group

Dig Endosc.33（1）:151-161, 2021

6.Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET study.

Shinzaki S, Matsuoka K, Tanaka H, Takeshima F, Kato S, Torisu T, Ohta Y, Watanabe K, Nakamura S, Yoshimura N, Kobayashi T, Shiotani A, Hirai F, Hiraoka S, Watanabe M, Matsuura M, Nishimoto S, Mizuno S, Iijima H, Takehara T, Naka T, Kanai T, Matsumoto T.

J Gastroenterol.56（6）：560-569, 2021

7.Does anti-tumor necrosis factor alpha prevent the recurrence of Crohn’s disease? Systematic review and meta-analysis.

Uchino M, Ikeuchi H, Hata K, Minagawa T, Horio Y, Kuwahara R, Nakamura S, Watanabe K, Saruta M, Fujii T, Kobayashi T, Sugimoto K, Hirai F, Esaki M, Hiraoka S, Matsuoka K, Shinzaki S, Matsuura M, Inoue N, Nakase H, Watanabe M.

J Gastroenterol Hepatol.36(4):864-872, 2021

8.Physician-patient communication affects patient satisfaction in treatment decision-making: a structural equation modelling analysis of a web-based survey in patients with ulcerative colitis.

Matsuoka K, Ishikawa H, Nakayama T, Honzawa Y, Maemoto A, Hirai F, Ueno F, Sato N, Susuta Y, Hibi T.

J Gastroenterol.56(9):843-855, 2021

9.Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trial.

Kobayashi T, Motoya S, Nakamura S, Yamamoto T, Nagahori M, Tanaka S, Hisamatsu T, Hirai F, Nakase H, Watanabe K, Matsumoto T, Tanaka M, Abe T, Suzuki Y, Watanabe M, Hibi T, HAYABUSA Study Group

Lancet Gastroenterol Hepatol.6(6):429-437, 2021

10.Identifying Bleeding Etiologies by Endoscopy Affected Outcomes in 10,342 Cases With Hematochezia: CODE BLUE-J Study.

Nagata N, Kobayashi K, Yamauchi A, Yamada A, Omori J, Ikeya T, Aoyama T, Tominaga N, Sato Y, Kishino T, Ishii N, Sawada T, Murata M, Takao A, Mizukami K, Kinjo K, Fujimori S, Uotani T, Fujita M, Sato H, Suzuki S, Narasaka T, Hayasaka J, Funabiki T, Kinjo Y, Mizuki A, Kiyotoki S, Mikami T, Gushima R, Fujii H, Fuyuno Y, Gunji N, Toya Y, Narimatsu K, Manabe N, Nagaike K, Kinjo T, Sumida Y, Funakoshi S, Kawagishi K, Matsuhashi T, Komaki Y, Miki K, Watanabe K, Fukuzawa M, Itoi T, Uemura N, Kawai T, Kaise M.

Am J Gastroenterol.116(11):2222-2234, 2021

11.Outcomes in high and low volume hospitals in patients with acute hematochezia in a cohort study.

Ishii N, Nagata N, Kobayashi K, Yamauchi A, Yamada A, Omori J, Ikeya T, Aoyama T, Tominaga N, Sato Y, Kishino T, Sawada T, Murata M, Takao A, Mizukami K, Kinjo K, Fujimori S, Uotani T, Fujita M, Sato H, Suzuki S, Narasaka T, Hayasaka J, Funabiki T, Kinjo Y, Mizuki A, Kiyotoki S, Mikami T, Gushima R, Fujii H, Fuyuno Y, Gunji N, Toya Y, Narimatsu K, Manabe N, Nagaike K, Kinjo T, Sumida Y, Funakoshi S, Kawagishi K, Matsuhashi T, Komaki Y, Miki K, Watanabe K, Omata F, Shiratori Y, Imamura N, Yano T, Kaise M.

Sci Repdoi: 10.1038/s41598-021-99832-6., 2021

12.Treatment strategies for reducing early and late recurrence of colonic diverticular bleeding based on stigmata of recent hemorrhage: a large multicenter study.

Gobinet MS, Nagata N, Kobayashi K, Yamauchi A, Yamada A, Omori J, Ikeya T, Aoyama T, Tominaga N, Sato Y, Kishino T, Ishii N, Sawada T, Murata M, Takao A, Mizukami K, Kinjo K, Fujimori S, Uotani T, Fujita M, Sato H, Suzuki S, Narasaka T, Hayasaka J, Funabiki T, Kinjo Y, Mizuki A, Kiyotoki S, Mikami T, Gushima R, Fujii H, Fuyuno Y, Gunji N, Toya Y, Narimatsu K, Manabe N, Nagaike K, Kinjo T, Sumida Y, Funakoshi S, Kawagishi K, Matsuhashi T, Komaki Y, Miki K, Watanabe K, Uemura N, Itawa E, Sugimoto M, Fukuzawa M, Kawai T, Kaise M, Itoi T.

Gastrointest Endosc.doi:10.1016/j.gie.2021.12.023., 2021

13.Elobixibat, an ileal bile acid transporter inhibitor, ameliorates non-alcoholic steatohepatitis in mice

Yamauchi R, Takedatsu H, Yokoyama K, Yamauchi E, Kawashima M, Nagata T, Uchida Y, Kitaguchi T, Higashi T, Fukuda H, Tsuchiya N, Takata K, Tanaka T, Morihara D, Takeyama Y, Shakado S, Sakisaka S, Hirai F.

Hepatol Int.15(2):392-404, 2021

14.Irsogladine maleate alters expression of a tight junction protein in portal hypertensive gastropathy.

Yokoyama K, Irie M, Tsuchiya N, Yamauchi E, Kawashima M, Miyayama T, Fukuda H, Yamauchi R, Umeda K, Takata K, Tanaka T, Inomata S, Morihara D, Takeyama Y, Shakado S, Sakisaka S, Hirai F.

J Gastroenterol Hepatol.36(5):1208-1215, 2021

15.本邦における小腸狭窄が疑われた患者に対するタグ非搭載　パテンシーカプセル検査の全国多施設前向き調査

中村正直、渡辺憲治、大宮直木、平井郁仁、大森鉄平、徳原大介、中路 幸之助、能田貞治、江崎幹宏、鮫島 由規則、後藤秀実、寺野　彰、田尻久雄、松井敏幸

Gastroenterol Endosc.63(10):2242-2252, 2021

16.Evidence-based clinical practice guidelines for inflammatory bowel disease 2020.

Nakase H, Uchino M, Shinzaki S, Matsuura M, Matsuoka K, Kobayashi T, Saruta M, Hirai F, Hata K, Hiraoka S, Esaki M, Sugimoto K, Fuji T, Watanabe K, Nakamura S, Inoue N, Itoh T, Naganuma M, Hisamatsu T, Watanabe M, Miwa H, Enomoto N, Shimosegawa T, Koike K.

J Gastroenterol.56（5）：489-526，2021

17.クローン病小腸狭窄に対する内視鏡的バルーン拡張術ガイドライン(小腸内視鏡診療ガイドライン追補)

山本博徳、矢野智則、荒木昭博、江﨑幹宏、大塚和朗、大宮直木、岡　志郎、仲瀬裕志、馬場重樹、平井郁仁、細江直樹、松田知己、三井啓吾、渡辺憲治、緒方晴彦、勝木伸一、松本主之、藤城光弘、藤本一眞、井上晴洋、久松理一、日本消化器内視鏡学会、日本消化器内視鏡学会ガイドライン委員会、ワーキング委員会、日本炎症性腸疾患学会、日本消化管学会、日本消化器病学会、日本小腸学会、厚生労働科学研究費補助金難治性疾患政策研究事業「難治性炎症性腸管障害に関する調査研究」班

Gastroenterol Endosc.63(10):2253-2275,2021

18.Long-term outcomes of endoscopic balloon dilation for intestinal strictures in patients with Crohn’s disease during maintenance treatment with anti-tumor necrosis factor alpha antibodies.

Takeda T, Kishi M, Takatsu N, Takada Y, Beppu T, Miyaoka M, Hisabe T, Ueki T, Arima H, Hirai F, Yao K.

Dig Endosc.34(3):517-525, 2022

19.Male-specific Association between Iron and Lipid Metabolism Changes and Erythroferrone after Hepatitis C Virus Eradication.

Inomata S, Morihara D, Anan A, Yamauchi E, Yamauchi R, Takata K, Tanaka T, Yokoyama K, Takeyama Y, Irie M, Shakado S, Sohda T, Sakisaka S, Hirai F.

Intern Med.61(4):461-467, 2022

20.Endoscopic direct clipping versus indirect clipping for colonic diverticular bleeding: A large multicenter cohort study.

Kishino T, Nagata N, Kobayashi K, Yamauchi A, Yamada A, Omori J, Ikeya T, Aoyama T, Tominaga N, Sato Y, Ishii N, Sawada T, Murata M, Takao A, Mizukami K, Kinjo K, Fujimori S, Uotani T, Fujita M, Sato H, Suzuki S, Narasaka T, Hayasaka J, Funabiki T, Kinjo Y, Mizuki A, Kiyotoki S, Mikami T, Gushima R, Fujii H, Fuyuno Y, Gunji N, Toya Y, Narimatsu K, Manabe N, Nagaike K, Kinjo T, Sumida Y, Funakoshi S, Kawagishi K, Matsuhashi T, Komaki Y, Miki K, Watanabe K, Kaise M.

United European Gastroenterol J.doi: 10.1002/ueg2.12197., 2022

21.Suppression of Local Tumor Progression in Perivascular Hepatocellular Carcinoma by Combination Therapy with Radiofrequency Ablation and Percutaneous Ethanol Injection: A Propensity Score Matching Analysis

Takata K, Tanakaa T, Anana A, Fukunaga A, Nagata T, Fukuda H, Yamauchi R, Kunimoto H, Yokoyama K, Morihara D, Takeyama Y, Iwata K, Shakado S, Sakisaka S, Hirai F.

Oncologydoi: 10.1159/000522374., 2022

22.AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study

Matsuoka K, Watanabe M, Ohmori T, Nakajima K, Ishida T, Ishiguro Y, Kanke K, Kobayashi K, Hirai F, Watanabe K, Mizusawa H, Kishida S, Miura Y, Ohta A, Kajioka T, Hibi T; AJM300 Study Group.

Lancet Gastroenterol Hepatol. doi: 10.1016/S2468-1253(22)00022-X., 2022

23.Efficacy and safety of filgotinib as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a post-hoc analysis of the phase 2b/3 SELECTION trial

Hibi T, Motoya S, Hisamatsu T, Hirai F, Watanabe K, Matsuoka K, Saruta M, Kobayashi T, Feagan BG, Tasset C, Besuyen R, Yun C, Crans G, Zhang J, Kondo A, Watanabe M.

Intest Res. doi: 10.5217/ir.2021.00143., 2022

24.Interim analysis of a multicenter registry study of COVID-19 patients with inflammatory bowel disease in Japan (J-COSMOS)

Nakase H, Hayashi Y, Hirayama D, Matsumoto T, Matsuura M, Iijima H, Matsuoka K, Ohmiya N, Ishihara S, Hirai F, Abukawa D, Hisamatsu T; J-COSMOS group.

J Gastroenterol. 57(3):174-184, 2022

25.Role of Serum Proteinase 3 Antineutrophil Cytoplasmic Antibodies in the Diagnosis, Evaluation of Disease Severity, and Clinical Course of Ulcerative Colitis

makiire S, Takedatsu H, Mitsuyama K, Sakisaka H, Tsuruta K, Morita M, Kuno N, Abe K, Funakoshi S, Ishibashi H, Yoshioka S, Torimura T, Hirai F.

Gut Liver. 16(1):92-100, 2022

26.Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Crohn’s Disease

Sands BE, Peyrin-Biroulet L, Kierkus J, Higgins PDR, Fischer M, Jairath V, Hirai F, D’Haens G, Belin RM, Miller D, Gomez-Valderas E, Naegeli AN, Tuttle JL, Pollack PF, Sandborn WJ.

Gastroenterology. 162(2):495-508, 2022

1.Novel Endoscopic Therapy for Gastric Varices Using Direct Forward-Viewing Endoscopic Ultrasonography.

Yokoyama K, Miyayama T, Uchida Y, Fukuda H, Yamauchi R, Tsuchiya N, Umeda K, Takata K, Tanaka T, Inomata S, Morihara D, Takeyama Y, Shakado S, Sakisaka S, Hirai F.

Case Rep Gastroenterol.15（1）：28-34,2021

2.Gastroesophageal Varices and Hyperplastic Nodules of the Liver in a Patient with Anorexia Nervosa.

Takata K, Nagata T, Uchida Y, Kitaguchi T, Higashi T, Fukuda H, Yamauchi R, Tsuchiya N, Tanaka T, Yokoyama K, Morihara D, Takeyama Y, Shakado S, Hamada Y, Yoshimitsu K, Sakisaka S, Hirai F.

Intern Med.60(19):3017-3112,2021

3.Eosinophilic Granuloma of the Liver Mimicking Metastatic Liver Tumor: A Case Report.

Uchida Y, Yokoyama K, Higashi T, Kitaguchi T, Fukuda H, Yamauchi R, Tsuchiya N, Fukunaga A, Umeda K, Takata K, Tanaka T, Takeyama Y, Shakado S, Sakisaka S, Hayashi H, Hamada Y, Nabeshima K, Hirai F.

Intern Med.doi:10.2169/internalmedicine.8438-21. 2021

4.A case of episodic angioedema with eosinophilia in an elderly woman with primary biliary cholangitis.

Iwashita H, Shakado S, Yasuda H, Tanabe T, Yamaguchi M, Irie M, Hirai F.

Clin J Gastroenterol.14(3):836-841,2021

5.Multiple focal fatty changes in the liver in patients with porphyria cutanea tarda: A case series and review of the literature.

Takata K, Fukunaga A, Nishizawa S, Uchida Y, Fukuyama M, Nagata T, Higashi T, Fukuda H, Yamauchi R, Tanaka T, Yokoyama K, Morihara D, Takeyama Y, Shakado S, Sakisaka S, Hirai F.

J Clin Ultrasound.doi: 10.1002/jcu.23108. 2021

6.Mass-forming adenomyomatosis in extrahepatic bile duct.

Ishida Y, Okabe Y, Hisaka T, Naito Y, Torimura T.

Gastrointest Endosc.93(2):522-524,2021

7.Duckbill-type antireflux self-expandable metal stent placement for post-choledochojejunostomy reflux cholangitis

Koga T, Hijioka S, Ishikawa Y, Ito K, Harai S, Okusaka T, Saito Y.

Endoscopy53(5):E174-E176,2021

8.Endoscopic ultrasound-guided choledochoduodenostomy without fistula dilation using a novel fully covered metallic stent with a 5.9-Fr ultra-thin delivery system

Koga T, Hijioka S, Hisada Y, Maruki Y, Nagashio Y, Okusaka T, Saito Y.

Endoscopy53(6):E223-E225,2021

9.腫瘍随伴症候群としての発熱を伴ったびまん型肝未分化癌の一剖検例

福田　祥、二村　聡、山内　涼、吉村雅代、川島素子、福田洋美、高田和英、田中　崇、森原大輔、横山圭二、竹山康章、釈迦堂敏、鍋島一樹、向坂彰太郎、平井郁仁

福岡大学医学紀要48(2), 143-147, 2021

10.Epstein-Barr Virus-positive Intestinal Diffuse Large B-cell Lymphoma in a Japanese Patient with Celiac Disease:First Reported Case and a Listerature Review.

Ishibashi H, Imakiire S, Goto M, Nomaru R, Shibata M, Matsuika H, Yasuda H, Yamashima T, Sakisaka H, Tanabe T, Matsuoka S, Kuno N, Abe K, Funakoshi S, Takamatsu Y, Hirai F and Takeshita M.

Intern Med.61(3):329-334,2022

11.Operative findings of the migrated stent into the abdominal cavity following endoscopic ultrasound-guided hepaticogastrostomy: Anchoring force of a novel self-expandable metal stent with an anti-migration system (with video)

Koga T, Ishida Y, Hirai F.

J Hepatobiliary Pancreat Sci. doi: 10.1002/jhbp.1109., 2022

1.潰瘍性大腸炎

平井郁仁

臨牀と研究98(5):9（525）-13（529）,2021

2.IBD診療現場のPros & Cons 生物学的製剤による寛解維持中に５-ASA製剤を続けるべきか？

平井郁仁

IBD Research15(1):43-47,2021

3.炎症性腸疾患のモニタリングにおける大腸内視鏡の意義と実際

平井郁仁、久能宣昭、阿部光市

日本消化器病学会雑誌118(3):203-211,2021

4.第４章　消化器系の基本薬の使い分け 潰瘍性大腸炎への免疫抑制薬はどう選ぶ？

平井郁仁

月刊薬事　臨時増刊号63(7):201(1381)-206(1386),2021

5.【IBDの診断と治療】クローン病の診断基準と鑑別疾患

平井郁仁

消化器内科3（4）：21-26，2021

6.小腸　治療　内視鏡的バルーン拡張術

平井郁仁

胃と腸56（5）：707，2021

7.「プレフレイル高齢大腸がん患者のための臨床的提言」 支持・緩和医療に関する提言

石黒　洋、石橋英樹、山口　崇、綿貫成明、華井明子、桜井なおみ、辻　哲也

日本大腸肛門病学会雑誌74（6）：349-356,2021

8.バルーン内視鏡による小腸腫瘍の診断と治療

阿部光市、久能宣昭、石橋英樹、濱田義浩、濱﨑　慎、平井郁仁

消化器内科3(12), 76-86, 2021

9.炎症性腸疾患の画像所見と鑑別診断

船越禎広、阿部光市、久能宣昭、柴田　衛、能丸遼平、山嶋友実、保田秀生、松岡弘樹、今給黎 宗、松岡　賢、田辺太郎、向坂秀人、石橋英樹、平井郁仁

胃と腸56(12), 1519-1526, 2021

10.A．疾患マネージメントに大きく変革がもたらされた病態 小腸狭窄性病変

平井郁仁

消化器内視鏡33(12)：1833-1842,2021

11.Medical Oncologistが知っておくべき、肝胆膵領域における最新の内視鏡処置

古賀毅彦、 肱岡　範,、真下翔太、河原　駿、村嶋佑美、川崎佑輝、北村英俊、原井正太、丸木雄太、大場彬博、永塩美邦、近藤俊輔、森実千種、上野秀樹、奥坂 拓志

腫瘍内科27(2):224-232,2021

12.胆膵内視鏡－介助者に必要な知識－

石田祐介、平井郁仁

九州消化器内視鏡技師会会誌33:38-45,2021

13.内視鏡介助技術向上に向けて～大腸内視鏡診療を中心に～

船越禎広、平井郁仁

九州消化器内視鏡技師会会誌33:46-48,2021

14.【炎症性腸疾患update-診断・治療の最新知見-】診断とモニタリングの進歩　小腸バルーン内視鏡とカプセル内視鏡の進歩

山嶋 友実, 平井 郁仁, 阿部 光市

日本臨床80(3):420-426, 2022

15.【炎症性腸疾患の粘膜治癒を再考する】Crohn病における小腸粘膜治癒評価の意義　X線の立場から

久能 宣昭, 阿部 光市, 船越 禎広, 石橋 英樹, 平井 郁仁

胃と腸57(2):165-172, 2022

16.【こんなときどうする】前投薬によるトラブル発生時の対応　キシロカイン、抗コリン薬、鎮静薬、プロポフォールなど

船越 禎広, 山嶋 友実, 柴田 衛, 能丸 遼平, 今給黎 宗, 向坂 秀人, 久能 宣昭, 石橋 英樹, 平井 郁仁

消化器内視鏡34(3):339-344,2022

1.腸管Behcet病、単純性潰瘍 専門医のための消化器病学　第３版

平井郁仁　（分担）　

医学書院pp.210-214,2021

2.11.内視鏡的拡張術　①クローン病狭窄病変への考え方とEBDの適応、②EBDの方法、③EBDの治療成績と合併症 クローン病の診療ガイドライン 第3版 （NPO法人 日本炎症性腸疾患協会（CCFJ）編)

平井郁仁（分担）

文光堂pp.64-66,2021

3.第１章　診断と分類 1. 概念・疫学、2. 診断へのアプローチ、3. 診断確定と鑑別疾患、4. 病態（病型、病期、重症度）の分類 潰瘍性大腸炎の診療ガイドライン 第4版 （NPO法人 日本炎症性腸疾患協会（CCFJ）編

平井郁仁（分担）

文光堂pp.10-16,2021

4.診断のTips No.42　ERCP下細胞診　適切な検体処理を行っていますか？ 教科書では教えてくれない！ 私の消化器内視鏡 Tips vol.2

石田祐介（分担）

医学書院pp.44, 2021

1.Concomitant use of an immunomodulator with ustekinumab as an induction therapy for Crohn’s disease: A systematic review and meta-analysis.

Yoshihara T, Shinzaki S, Amano T, Iijima H, Takehara T, Inoue N, Uchino M, Esaki M, Kobayashi T, Saruta M, Sugimoto K, Nakamura S, Hata K, Hirai F, Hiraoka S, Fujii T, Matsuura M, Matsuoka K, Watanabe K, Nakase H, Watanabe M.

J Gastroenterol Hepatol.36（7）：1744-1753， 2021

2.Adrenomedullin for steroid-resistant ulcerative colitis: a randomized, double-blind, placebo-controlled phase-2a clinical trial.

Kita T, Ashizuka S, Ohmiya N, Yamamoto T, Kanai T, Motoya S, Hirai F, Nakase H, Moriyama T, Nakamura M, Suzuki Y, Kanmura S, Kobayashi T, Ohi H, Nozaki R, Mitsuyama K, Yamamoto S, Inatsu H, Watanabe K, Hibi T, Kitamura K.

J Gastroenterol.56(2):147-157, 2021

3.Novel ultrathin double-balloon endoscopy for the diagnosis ofsmall-bowel diseases: a multicenter nonrandomized study.

Nakamura M, Yano T, Esaki M, Oka S, Mitsui K, Hirai F, Kawasaki K, Fujishiro M, Torisu T, Tanaka S, Iwakiri K, Kishi M, Matsumoto T, Yamamoto H.

Endosc.53(8):802-814, 2021

4.Intestinal cancer in patients with Crohn’s disease: A systematic review and meta-analysis.

Uchino M, Ikeuchi H, Hata K, Minagawa T, Horio Y, Kuwahara R, Nakamura S, Watanabe K, Saruta M, Fujii T, Kobayashi T, Sugimoto K, Hirai F, Esaki M, Hiraoka S, Matsuoka K, Shinzaki S, Matsuura M, Inoue N, Nakase H, Watanabe M.

J Gastroenterol Hepatol.36（2）：329-336, 2021

5.Tag-less patency capsule for suspected small bowel stenosis: Nationwide multicenter prospective study in Japan.

Nakamura M, Watanabe K, Ohmiya N, Hirai F, Omori T, Tokuhara D, Nakaji K, Nouda S, Esaki M, Sameshima Y, Goto H, Terano A, Tajiri H, Matsui T, J-POP study group

Dig Endosc.33（1）:151-161, 2021

6.Leucine-rich alpha-2 glycoprotein is a potential biomarker to monitor disease activity in inflammatory bowel disease receiving adalimumab: PLANET study.

Shinzaki S, Matsuoka K, Tanaka H, Takeshima F, Kato S, Torisu T, Ohta Y, Watanabe K, Nakamura S, Yoshimura N, Kobayashi T, Shiotani A, Hirai F, Hiraoka S, Watanabe M, Matsuura M, Nishimoto S, Mizuno S, Iijima H, Takehara T, Naka T, Kanai T, Matsumoto T.

J Gastroenterol.56（6）：560-569, 2021

7.Does anti-tumor necrosis factor alpha prevent the recurrence of Crohn’s disease? Systematic review and meta-analysis.

Uchino M, Ikeuchi H, Hata K, Minagawa T, Horio Y, Kuwahara R, Nakamura S, Watanabe K, Saruta M, Fujii T, Kobayashi T, Sugimoto K, Hirai F, Esaki M, Hiraoka S, Matsuoka K, Shinzaki S, Matsuura M, Inoue N, Nakase H, Watanabe M.

J Gastroenterol Hepatol.36(4):864-872, 2021

8.Physician-patient communication affects patient satisfaction in treatment decision-making: a structural equation modelling analysis of a web-based survey in patients with ulcerative colitis.

Matsuoka K, Ishikawa H, Nakayama T, Honzawa Y, Maemoto A, Hirai F, Ueno F, Sato N, Susuta Y, Hibi T.

J Gastroenterol.56(9):843-855, 2021

9.Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trial.

Kobayashi T, Motoya S, Nakamura S, Yamamoto T, Nagahori M, Tanaka S, Hisamatsu T, Hirai F, Nakase H, Watanabe K, Matsumoto T, Tanaka M, Abe T, Suzuki Y, Watanabe M, Hibi T, HAYABUSA Study Group

Lancet Gastroenterol Hepatol.6(6):429-437, 2021

10.Identifying Bleeding Etiologies by Endoscopy Affected Outcomes in 10,342 Cases With Hematochezia: CODE BLUE-J Study.

Nagata N, Kobayashi K, Yamauchi A, Yamada A, Omori J, Ikeya T, Aoyama T, Tominaga N, Sato Y, Kishino T, Ishii N, Sawada T, Murata M, Takao A, Mizukami K, Kinjo K, Fujimori S, Uotani T, Fujita M, Sato H, Suzuki S, Narasaka T, Hayasaka J, Funabiki T, Kinjo Y, Mizuki A, Kiyotoki S, Mikami T, Gushima R, Fujii H, Fuyuno Y, Gunji N, Toya Y, Narimatsu K, Manabe N, Nagaike K, Kinjo T, Sumida Y, Funakoshi S, Kawagishi K, Matsuhashi T, Komaki Y, Miki K, Watanabe K, Fukuzawa M, Itoi T, Uemura N, Kawai T, Kaise M.

Am J Gastroenterol.116(11):2222-2234, 2021

11.Outcomes in high and low volume hospitals in patients with acute hematochezia in a cohort study.

Ishii N, Nagata N, Kobayashi K, Yamauchi A, Yamada A, Omori J, Ikeya T, Aoyama T, Tominaga N, Sato Y, Kishino T, Sawada T, Murata M, Takao A, Mizukami K, Kinjo K, Fujimori S, Uotani T, Fujita M, Sato H, Suzuki S, Narasaka T, Hayasaka J, Funabiki T, Kinjo Y, Mizuki A, Kiyotoki S, Mikami T, Gushima R, Fujii H, Fuyuno Y, Gunji N, Toya Y, Narimatsu K, Manabe N, Nagaike K, Kinjo T, Sumida Y, Funakoshi S, Kawagishi K, Matsuhashi T, Komaki Y, Miki K, Watanabe K, Omata F, Shiratori Y, Imamura N, Yano T, Kaise M.

Sci Repdoi: 10.1038/s41598-021-99832-6., 2021

12.Treatment strategies for reducing early and late recurrence of colonic diverticular bleeding based on stigmata of recent hemorrhage: a large multicenter study.

Gobinet MS, Nagata N, Kobayashi K, Yamauchi A, Yamada A, Omori J, Ikeya T, Aoyama T, Tominaga N, Sato Y, Kishino T, Ishii N, Sawada T, Murata M, Takao A, Mizukami K, Kinjo K, Fujimori S, Uotani T, Fujita M, Sato H, Suzuki S, Narasaka T, Hayasaka J, Funabiki T, Kinjo Y, Mizuki A, Kiyotoki S, Mikami T, Gushima R, Fujii H, Fuyuno Y, Gunji N, Toya Y, Narimatsu K, Manabe N, Nagaike K, Kinjo T, Sumida Y, Funakoshi S, Kawagishi K, Matsuhashi T, Komaki Y, Miki K, Watanabe K, Uemura N, Itawa E, Sugimoto M, Fukuzawa M, Kawai T, Kaise M, Itoi T.

Gastrointest Endosc.doi:10.1016/j.gie.2021.12.023., 2021

13.Elobixibat, an ileal bile acid transporter inhibitor, ameliorates non-alcoholic steatohepatitis in mice

Yamauchi R, Takedatsu H, Yokoyama K, Yamauchi E, Kawashima M, Nagata T, Uchida Y, Kitaguchi T, Higashi T, Fukuda H, Tsuchiya N, Takata K, Tanaka T, Morihara D, Takeyama Y, Shakado S, Sakisaka S, Hirai F.

Hepatol Int.15(2):392-404, 2021

14.Irsogladine maleate alters expression of a tight junction protein in portal hypertensive gastropathy.

Yokoyama K, Irie M, Tsuchiya N, Yamauchi E, Kawashima M, Miyayama T, Fukuda H, Yamauchi R, Umeda K, Takata K, Tanaka T, Inomata S, Morihara D, Takeyama Y, Shakado S, Sakisaka S, Hirai F.

J Gastroenterol Hepatol.36(5):1208-1215, 2021

15.本邦における小腸狭窄が疑われた患者に対するタグ非搭載　パテンシーカプセル検査の全国多施設前向き調査

中村正直、渡辺憲治、大宮直木、平井郁仁、大森鉄平、徳原大介、中路 幸之助、能田貞治、江崎幹宏、鮫島 由規則、後藤秀実、寺野　彰、田尻久雄、松井敏幸

Gastroenterol Endosc.63(10):2242-2252, 2021

16.Evidence-based clinical practice guidelines for inflammatory bowel disease 2020.

Nakase H, Uchino M, Shinzaki S, Matsuura M, Matsuoka K, Kobayashi T, Saruta M, Hirai F, Hata K, Hiraoka S, Esaki M, Sugimoto K, Fuji T, Watanabe K, Nakamura S, Inoue N, Itoh T, Naganuma M, Hisamatsu T, Watanabe M, Miwa H, Enomoto N, Shimosegawa T, Koike K.

J Gastroenterol.56（5）：489-526，2021

17.クローン病小腸狭窄に対する内視鏡的バルーン拡張術ガイドライン(小腸内視鏡診療ガイドライン追補)

山本博徳、矢野智則、荒木昭博、江﨑幹宏、大塚和朗、大宮直木、岡　志郎、仲瀬裕志、馬場重樹、平井郁仁、細江直樹、松田知己、三井啓吾、渡辺憲治、緒方晴彦、勝木伸一、松本主之、藤城光弘、藤本一眞、井上晴洋、久松理一、日本消化器内視鏡学会、日本消化器内視鏡学会ガイドライン委員会、ワーキング委員会、日本炎症性腸疾患学会、日本消化管学会、日本消化器病学会、日本小腸学会、厚生労働科学研究費補助金難治性疾患政策研究事業「難治性炎症性腸管障害に関する調査研究」班

Gastroenterol Endosc.63(10):2253-2275,2021

18.Long-term outcomes of endoscopic balloon dilation for intestinal strictures in patients with Crohn’s disease during maintenance treatment with anti-tumor necrosis factor alpha antibodies.

Takeda T, Kishi M, Takatsu N, Takada Y, Beppu T, Miyaoka M, Hisabe T, Ueki T, Arima H, Hirai F, Yao K.

Dig Endosc.34(3):517-525, 2022

19.Male-specific Association between Iron and Lipid Metabolism Changes and Erythroferrone after Hepatitis C Virus Eradication.

Inomata S, Morihara D, Anan A, Yamauchi E, Yamauchi R, Takata K, Tanaka T, Yokoyama K, Takeyama Y, Irie M, Shakado S, Sohda T, Sakisaka S, Hirai F.

Intern Med.61(4):461-467, 2022

20.Endoscopic direct clipping versus indirect clipping for colonic diverticular bleeding: A large multicenter cohort study.

Kishino T, Nagata N, Kobayashi K, Yamauchi A, Yamada A, Omori J, Ikeya T, Aoyama T, Tominaga N, Sato Y, Ishii N, Sawada T, Murata M, Takao A, Mizukami K, Kinjo K, Fujimori S, Uotani T, Fujita M, Sato H, Suzuki S, Narasaka T, Hayasaka J, Funabiki T, Kinjo Y, Mizuki A, Kiyotoki S, Mikami T, Gushima R, Fujii H, Fuyuno Y, Gunji N, Toya Y, Narimatsu K, Manabe N, Nagaike K, Kinjo T, Sumida Y, Funakoshi S, Kawagishi K, Matsuhashi T, Komaki Y, Miki K, Watanabe K, Kaise M.

United European Gastroenterol J.doi: 10.1002/ueg2.12197., 2022

21.Suppression of Local Tumor Progression in Perivascular Hepatocellular Carcinoma by Combination Therapy with Radiofrequency Ablation and Percutaneous Ethanol Injection: A Propensity Score Matching Analysis

Takata K, Tanakaa T, Anana A, Fukunaga A, Nagata T, Fukuda H, Yamauchi R, Kunimoto H, Yokoyama K, Morihara D, Takeyama Y, Iwata K, Shakado S, Sakisaka S, Hirai F.

Oncologydoi: 10.1159/000522374., 2022

22.AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study

Matsuoka K, Watanabe M, Ohmori T, Nakajima K, Ishida T, Ishiguro Y, Kanke K, Kobayashi K, Hirai F, Watanabe K, Mizusawa H, Kishida S, Miura Y, Ohta A, Kajioka T, Hibi T; AJM300 Study Group.

Lancet Gastroenterol Hepatol. doi: 10.1016/S2468-1253(22)00022-X., 2022

23.Efficacy and safety of filgotinib as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a post-hoc analysis of the phase 2b/3 SELECTION trial

Hibi T, Motoya S, Hisamatsu T, Hirai F, Watanabe K, Matsuoka K, Saruta M, Kobayashi T, Feagan BG, Tasset C, Besuyen R, Yun C, Crans G, Zhang J, Kondo A, Watanabe M.

Intest Res. doi: 10.5217/ir.2021.00143., 2022

24.Interim analysis of a multicenter registry study of COVID-19 patients with inflammatory bowel disease in Japan (J-COSMOS)

Nakase H, Hayashi Y, Hirayama D, Matsumoto T, Matsuura M, Iijima H, Matsuoka K, Ohmiya N, Ishihara S, Hirai F, Abukawa D, Hisamatsu T; J-COSMOS group.

J Gastroenterol. 57(3):174-184, 2022

25.Role of Serum Proteinase 3 Antineutrophil Cytoplasmic Antibodies in the Diagnosis, Evaluation of Disease Severity, and Clinical Course of Ulcerative Colitis

makiire S, Takedatsu H, Mitsuyama K, Sakisaka H, Tsuruta K, Morita M, Kuno N, Abe K, Funakoshi S, Ishibashi H, Yoshioka S, Torimura T, Hirai F.

Gut Liver. 16(1):92-100, 2022

26.Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Crohn’s Disease

Sands BE, Peyrin-Biroulet L, Kierkus J, Higgins PDR, Fischer M, Jairath V, Hirai F, D’Haens G, Belin RM, Miller D, Gomez-Valderas E, Naegeli AN, Tuttle JL, Pollack PF, Sandborn WJ.

Gastroenterology. 162(2):495-508, 2022

1.Novel Endoscopic Therapy for Gastric Varices Using Direct Forward-Viewing Endoscopic Ultrasonography.

Yokoyama K, Miyayama T, Uchida Y, Fukuda H, Yamauchi R, Tsuchiya N, Umeda K, Takata K, Tanaka T, Inomata S, Morihara D, Takeyama Y, Shakado S, Sakisaka S, Hirai F.

Case Rep Gastroenterol.15（1）：28-34,2021

2.Gastroesophageal Varices and Hyperplastic Nodules of the Liver in a Patient with Anorexia Nervosa.

Takata K, Nagata T, Uchida Y, Kitaguchi T, Higashi T, Fukuda H, Yamauchi R, Tsuchiya N, Tanaka T, Yokoyama K, Morihara D, Takeyama Y, Shakado S, Hamada Y, Yoshimitsu K, Sakisaka S, Hirai F.

Intern Med.60(19):3017-3112,2021

3.Eosinophilic Granuloma of the Liver Mimicking Metastatic Liver Tumor: A Case Report.

Uchida Y, Yokoyama K, Higashi T, Kitaguchi T, Fukuda H, Yamauchi R, Tsuchiya N, Fukunaga A, Umeda K, Takata K, Tanaka T, Takeyama Y, Shakado S, Sakisaka S, Hayashi H, Hamada Y, Nabeshima K, Hirai F.

Intern Med.doi:10.2169/internalmedicine.8438-21. 2021

4.A case of episodic angioedema with eosinophilia in an elderly woman with primary biliary cholangitis.

Iwashita H, Shakado S, Yasuda H, Tanabe T, Yamaguchi M, Irie M, Hirai F.

Clin J Gastroenterol.14(3):836-841,2021

5.Multiple focal fatty changes in the liver in patients with porphyria cutanea tarda: A case series and review of the literature.

Takata K, Fukunaga A, Nishizawa S, Uchida Y, Fukuyama M, Nagata T, Higashi T, Fukuda H, Yamauchi R, Tanaka T, Yokoyama K, Morihara D, Takeyama Y, Shakado S, Sakisaka S, Hirai F.

J Clin Ultrasound.doi: 10.1002/jcu.23108. 2021

6.Mass-forming adenomyomatosis in extrahepatic bile duct.

Ishida Y, Okabe Y, Hisaka T, Naito Y, Torimura T.

Gastrointest Endosc.93(2):522-524,2021

7.Duckbill-type antireflux self-expandable metal stent placement for post-choledochojejunostomy reflux cholangitis

Koga T, Hijioka S, Ishikawa Y, Ito K, Harai S, Okusaka T, Saito Y.

Endoscopy53(5):E174-E176,2021

8.Endoscopic ultrasound-guided choledochoduodenostomy without fistula dilation using a novel fully covered metallic stent with a 5.9-Fr ultra-thin delivery system

Koga T, Hijioka S, Hisada Y, Maruki Y, Nagashio Y, Okusaka T, Saito Y.

Endoscopy53(6):E223-E225,2021

9.腫瘍随伴症候群としての発熱を伴ったびまん型肝未分化癌の一剖検例

福田　祥、二村　聡、山内　涼、吉村雅代、川島素子、福田洋美、高田和英、田中　崇、森原大輔、横山圭二、竹山康章、釈迦堂敏、鍋島一樹、向坂彰太郎、平井郁仁

福岡大学医学紀要48(2), 143-147, 2021

10.Epstein-Barr Virus-positive Intestinal Diffuse Large B-cell Lymphoma in a Japanese Patient with Celiac Disease:First Reported Case and a Listerature Review.

Ishibashi H, Imakiire S, Goto M, Nomaru R, Shibata M, Matsuika H, Yasuda H, Yamashima T, Sakisaka H, Tanabe T, Matsuoka S, Kuno N, Abe K, Funakoshi S, Takamatsu Y, Hirai F and Takeshita M.

Intern Med.61(3):329-334,2022

11.Operative findings of the migrated stent into the abdominal cavity following endoscopic ultrasound-guided hepaticogastrostomy: Anchoring force of a novel self-expandable metal stent with an anti-migration system (with video)

Koga T, Ishida Y, Hirai F.

J Hepatobiliary Pancreat Sci. doi: 10.1002/jhbp.1109., 2022

1.潰瘍性大腸炎

平井郁仁

臨牀と研究98(5):9（525）-13（529）,2021

2.IBD診療現場のPros & Cons 生物学的製剤による寛解維持中に５-ASA製剤を続けるべきか？

平井郁仁

IBD Research15(1):43-47,2021

3.炎症性腸疾患のモニタリングにおける大腸内視鏡の意義と実際

平井郁仁、久能宣昭、阿部光市

日本消化器病学会雑誌118(3):203-211,2021

4.第４章　消化器系の基本薬の使い分け 潰瘍性大腸炎への免疫抑制薬はどう選ぶ？

平井郁仁

月刊薬事　臨時増刊号63(7):201(1381)-206(1386),2021

5.【IBDの診断と治療】クローン病の診断基準と鑑別疾患

平井郁仁

消化器内科3（4）：21-26，2021

6.小腸　治療　内視鏡的バルーン拡張術

平井郁仁

胃と腸56（5）：707，2021

7.「プレフレイル高齢大腸がん患者のための臨床的提言」 支持・緩和医療に関する提言

石黒　洋、石橋英樹、山口　崇、綿貫成明、華井明子、桜井なおみ、辻　哲也

日本大腸肛門病学会雑誌74（6）：349-356,2021

8.バルーン内視鏡による小腸腫瘍の診断と治療

阿部光市、久能宣昭、石橋英樹、濱田義浩、濱﨑　慎、平井郁仁

消化器内科3(12), 76-86, 2021

9.炎症性腸疾患の画像所見と鑑別診断

船越禎広、阿部光市、久能宣昭、柴田　衛、能丸遼平、山嶋友実、保田秀生、松岡弘樹、今給黎 宗、松岡　賢、田辺太郎、向坂秀人、石橋英樹、平井郁仁

胃と腸56(12), 1519-1526, 2021

10.A．疾患マネージメントに大きく変革がもたらされた病態 小腸狭窄性病変

平井郁仁

消化器内視鏡33(12)：1833-1842,2021

11.Medical Oncologistが知っておくべき、肝胆膵領域における最新の内視鏡処置

古賀毅彦、 肱岡　範,、真下翔太、河原　駿、村嶋佑美、川崎佑輝、北村英俊、原井正太、丸木雄太、大場彬博、永塩美邦、近藤俊輔、森実千種、上野秀樹、奥坂 拓志

腫瘍内科27(2):224-232,2021

12.胆膵内視鏡－介助者に必要な知識－

石田祐介、平井郁仁

九州消化器内視鏡技師会会誌33:38-45,2021

13.内視鏡介助技術向上に向けて～大腸内視鏡診療を中心に～

船越禎広、平井郁仁

九州消化器内視鏡技師会会誌33:46-48,2021

14.【炎症性腸疾患update-診断・治療の最新知見-】診断とモニタリングの進歩　小腸バルーン内視鏡とカプセル内視鏡の進歩

山嶋 友実, 平井 郁仁, 阿部 光市

日本臨床80(3):420-426, 2022

15.【炎症性腸疾患の粘膜治癒を再考する】Crohn病における小腸粘膜治癒評価の意義　X線の立場から

久能 宣昭, 阿部 光市, 船越 禎広, 石橋 英樹, 平井 郁仁

胃と腸57(2):165-172, 2022

16.【こんなときどうする】前投薬によるトラブル発生時の対応　キシロカイン、抗コリン薬、鎮静薬、プロポフォールなど

船越 禎広, 山嶋 友実, 柴田 衛, 能丸 遼平, 今給黎 宗, 向坂 秀人, 久能 宣昭, 石橋 英樹, 平井 郁仁

消化器内視鏡34(3):339-344,2022

1.腸管Behcet病、単純性潰瘍 専門医のための消化器病学　第３版

平井郁仁　（分担）　

医学書院pp.210-214,2021

2.11.内視鏡的拡張術　①クローン病狭窄病変への考え方とEBDの適応、②EBDの方法、③EBDの治療成績と合併症 クローン病の診療ガイドライン 第3版 （NPO法人 日本炎症性腸疾患協会（CCFJ）編)

平井郁仁（分担）

文光堂pp.64-66,2021

3.第１章　診断と分類 1. 概念・疫学、2. 診断へのアプローチ、3. 診断確定と鑑別疾患、4. 病態（病型、病期、重症度）の分類 潰瘍性大腸炎の診療ガイドライン 第4版 （NPO法人 日本炎症性腸疾患協会（CCFJ）編

平井郁仁（分担）

文光堂pp.10-16,2021

4.診断のTips No.42　ERCP下細胞診　適切な検体処理を行っていますか？ 教科書では教えてくれない！ 私の消化器内視鏡 Tips vol.2

石田祐介（分担）

医学書院pp.44, 2021

1.Endoscopic and clinicopathological characteristics of colorectal T/NK cell lymphoma.

Ishibashi H, Nimura S, Hirai F, Harada N, Iwasaki H, Kawauchi S, Oshiro Y, Matsuyama A, Nakamura S, Takamatsu T, Yonemasu H, Shimokama T, Takeshita M.

Diagn Pathol 15(1):128, doi:10.1186, 2020

2.Systematic review with meta-analysis: efficacy of balloon-assisted enteroscopy for dilation of small bowel Crohn’s disease strictures.

Dominik Bettenworth, Arne Bokemeyer, Lei Kou, Rocio Lopez, James F Bena, Sara El Ouali, Ren Mao, Satya Kurada, Amit Bhatt, Torsten Beyna, Brendan Halloran, Matthew Reeson, Hosomi S, Kishi M, Hirai F, Ohmiya N, Florian Rieder .

Aliment Pharmacol Ther 52(7):1104-1116,2020

3.Does anti-tumor necrosis factor alpha prevent the recurrence of Crohn’s disease? Systematic review and meta-analysis.

Uchino M, Ikeuchi H, Hata K, Minagawa T, Horio Y, Kuwahara R, Nakamura S, Watanabe K, Saruta M, Fujii T, Kobayashi T, Sugimoto K, Hirai F, Esaki M, Hiraoka S, Matsuoka K, Shinzaki S, Matsuura M, Inoue N, Nakase H, Watanabe M.

J Gastroenterol Hepatol. doi: 10.1111/jgh.15288. Online ahead of print. 2020.

4.Expert Opinions on the Current Therapeutic Management of Inflammatory Bowel Disease during the COVID-19 Pandemic: Japan IBD COVID-19 Taskforce, Intractable Diseases, the Health and Labor Sciences Research.

Nakase H, Matsumoto T, Matsuura M, Iijima H, Matsuoka K, Ohmiya N, Ishihara S, Hirai F, Wagatsuma K, Yokoyama Y, Hisamatsu T.

Digestion 4:1-9,2020

5.Long-Term Follow-Up of Targeted Biopsy Yield (LOFTY Study) in Ulcerative Colitis Surveillance Colonoscopy.

Hata K, Ishihara S, Ajioka Y, Mitsuyama K, Watanabe K, Hanai H, Kunisaki R, Nakase H, Matsuda K, Iwakiri R, Hida N, Tanaka S, Takeuchi Y, Shinozaki M, Ogata N, Moriichi K, Hirai F, Sugihara K, Hisamatsu T, Suzuki Y, Watanabe M, Hibi T.

J Clin Med 9(7):2286-2301,2020

6.Novel ultrathin double-balloon endoscopy for the diagnosis of small-bowel diseases: a multicenter nonrandomized study

Nakamura M, Yano T, Esaki M, Oka S, Mitsui K, Hirai F, Kawasaki K, Fujishiro M, Torisu T, Tanaka S, Iwakiri K, Kishi M, Matsumoto T, Yamamoto H.

Endoscopy doi: 10.1055/a-1243-0226. Online ahead of print.　2020

7.Efficacy of Granulocyte and Monocyte Adsorptive Apheresis in Patients With Inflammatory Bowel Disease Showing Lost Response to Infliximab.

Yokoyama Y, Sawada K, Aoyama N, Yoshimura N, Sako M, Hirai F, Kashiwagi N, Suzuki Y

JJ Crohns Colitis. 14(9):1264-1273, 2020

8.Indigo naturalis is effective even in treatment-refractory patients with ulcerative colitis: a post hoc analysis from the INDIGO study.

Naganuma M, Sugimoto S, Fukuda T, Mitsuyama K, Kobayashi T, Yoshimura N, Ohi H, Tanaka S, Andoh A, Ohmiya N, Saigusa K, Yamamoto T, Morohoshi Y, Ichikawa H, Matsuoka K, Hisamatsu T, Watanabe K, Mizuno S, Abe T, Suzuki Y, Kanai T; INDIGO Study Group

J Gastroenterol. 55(2):169-180,2020

9.Pilot study of tenofovir disoproxil fumarate and pegylated interferon-alpha 2a add-on therapy in Japanese patients with chronic hepatitis B.

Matsumoto A, Nishiguchi S, Enomoto H, Tanaka Y, Shinkai N, Okuse C, Jong-Hon Kang, Matsui T, Miyase S, Yatsuhashi H, Nagaoka S, Kanda T, Enomoto M, Yamada R, Hiramatsu N, Saito S, Takaguchi K, Ito K, Masaki T, Morihara D, Tsuge M, Chayama K, Ikeda F, Kagawa T, Kondo Y, Murata K, Tanaka E.

J Gastroenterol 55(10):977-989,2020

10.The Efficacy and Therapeutic Outcome of Bipolar Radiofrequency Ablation for the Treatment for Hepatocellular Carcinoma in the Real-World Setting, Compared with Monopolar Radiofrequency Ablation Conducted during the Same Period.

Tanaka T, Takata K, Kunimoto H, Fukuda H, Yamauchi R, Tsuchiya N, Inomata S, Yokoyama K, Morihara D, Takeyama Y, Shakado S, Sakisaka S, Hirai F.

Oncology 98(12):859-868,2020

11.Reduction in Tumor Stain at 2 Weeks after Treatment Initiation Is a Predictor of the Efficacy of Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma.

Kunimoto H, Shakado S, Tanaka T, Takata K, Yamauchi R, Fukuda H, Tsuchiya N, Yokoyama K, Morihara D, Takeyama Y, Hirai F, Sakisaka S.

Oncology 98(11):779-786,2020

12.Exploratory Research on the Relationship between Human Gut Microbiota and Portal Hypertension.

Yokoyama K, Tsuchiya N, Yamauchi R, Miyayama T, Uchida Y, Shibata K, Fukuda H, Umeda K, Takata K, Tanaka T, Inomata S, Morihara D, Takeyama Y, Shakado S, Sakisaka S, Hirai F.

Intern Med. 59(17):2089-2094,2020

13.Irsogladine maleate alters expression of a tight junction protein in portal hypertensive gastropathy.

Yokoyama K, Irie M, Tsuchiya N, Yamauchi E, Kawashima M, Miyayama T, Fukuda H, Yamauchi R, Umeda K, Takata K, Tanaka T, Inomata S, Morihara D, Takeyama Y, Shakado S, Sakisaka S, Hirai F.

J Gastroenterol Hepatol doi:10.1111/jgh.15259. Online ahead of print.2020 Sep 14.

14.Plasma Lipid Profiling of Three Types of Drug-Induced Liver Injury in Japanese Patients: A Preliminary Study.

Saito K, Kagawa T, Tsuji K, Kumagai Y, Sato K, Sakisaka S, Sakamoto N, Aiso M, Hirose S, Mori N, Tanaka R, Uraoka T, Takata K, Ogawa K, Mori K, Sato M, Nishiya T, Takamatsu K, Arakawa N, Izumi T, Ohno Y, Saito Y, Takikawa H.

Metabolites 10(9), 355． doi.org/10.3390/metabo10090355.2020

15.Adrenomedullin for steroid-resistant ulcerative colitis: a randomized, double-blind, placebo-controlled phase-2a clinical trial

Kita T, Ashizuka S, Ohmiya N, Yamamoto T, Kanai T, Motoya S, Hirai F, Nakase H, Moriyama T, Nakamura M, Suzuki Y, Kanmura S, Kobayashi T, Ohi H, Nozaki R, Mitsuyama K, Yamamoto S, Inatsu H, Watanabe K, Hibi T, Kitamura K.

Journal of Gastroenterology 56(2):147-157,2021

16.Elobixibat, an ileal bile acid transporter inhibitor, ameliorates non-alcoholic steatohepatitis in mice

Yamauchi R, Takedatsu H, Yokoyama K, Yamauchi E, Kawashima M, Nagata T, Uchida Y, Kitaguchi T, Higashi T, Fukuda H, Tsuchiya N, Takata K, Tanaka T, Morihara D, Takeyama Y, Shakado S, Sakisaka S, Hirai F.

Hepatol Int. doi:10.1007/s12072-020-10107-0. Online ahead of print. 2021.Jan.

17.Concomitant use of an immunomodulator with ustekinumab as an induction therapy for Crohn’s disease: A systematic review and meta-analysis.

Yoshihara T, Shinzaki S, Amano T, Iijima H, Takehara T, Inoue N, Uchino M, Esaki M, Kobayashi T, Saruta M, Sugimoto K, Nakamura S, Hata K, Hirai F, Hiraoka S, Fujii T, Matsuura M, Matsuoka K, Watanabe K, Nakase H, Watanabe M.

J Gastroenterol Hepatol doi:10.1111/jgh.15401. Online ahead of print.2021 Jan 15.

18.Intestinal cancer in patients with Crohn’s disease: A systematic review and meta-analysis.

Uchino M, Ikeuchi H, Hata K, Minagawa T, Horio Y, Kuwahara R, Nakamura S, Watanabe K, Saruta M, Fujii T, Kobayashi T, Sugimoto K, Hirai F, Esaki M, Hiraoka S, Matsuoka K, Shinzaki S, Matsuura M, Inoue N, Nakase H, Watanabe M.

J Gastroenterol Hepatol 36(2):329-336,2021

19.Tag-less patency capsule for suspected small bowel stenosis: Nationwide multicenter prospective study in Japan.

Nakamura M, Watanabe K, Ohmiya N, Hirai F, Omori T, Tokuhara D, Nakaji K, Nouda S, Esaki M, Sameshima Y, Goto H, Terano A, Tajiri H, Matsui T; J-POP study group.

Dig Endosc. 33(1):151-161,2021

20.Topical Therapy with Antisense Tumor Necrosis Factor Alpha Using Novel -Glucan-Based Drug Delivery System Ameliorates Intestinal Inflammation.

Sakisaka H, Takedatsu H, Mitsuyama K, Mochizuki S, Sakurai K, Sakisaka S, Hirai F.

Int J Mol Sci 21(2):pii: E683. doi: 10.3390/ijms21020683,2020

21.福岡大学病院における「免疫抑制・化学療法による発症するB型肝炎ガイドライン」の遵守状況

山内　涼、高田和英、森原大輔、大倉野 将広、宮山隆志、土屋直壮、田中　崇、横山圭二、竹山康章、釈迦堂 敏、向坂彰太郎、平井郁仁

福岡大学医学紀要 47(1):21-29, 2020

22.Irregularly branched microvessels as visualized by magnifying endoscopy: a reliable marker for predicting deep submucosal invasion of superficial esophageal squamous cell carcinoma.

Ono Y, Takaki Y, Yao K, Ishikawa S, Miyaoka M, Yano Y, Nagahama T, Hisabe T, Hirai F, Ueki T, Ota A, Tanabe H, Haraoka S, Iwashita A, Mikami K, Maekawa T.

Endosc Int Open 08(03):E234-E240,2020

1.Unresectable Ectopic Hepatocellular Carcinoma Treated with Sorafenib.

Yi-Ling Ko, Takata K, Tanaka T, Ohishi J, Takeshita M, Yamauchi R, Fukuda H, Miyayama T, Uchida Y, Yokoyama K, Morihara D, Takeyama Y, Shakado S, Sakisaka S, Hirai F.

Case Reports in Gastroenterology 14:226-233, 2020

2.Two Cases of Hepatocellular Carcinoma Arising Over 20 Years after a Sustained Virologic Response Following Interferon Therapy for Chronic Hepatitis C.

Takata K, Ishii F, Uchida Y, Fukuda H, Yamauchi R, Umeda K, Tsuchiya N, Tanaka T, Yokoyama K, Morihara D, Takeyama Y, Shakado S, Sakisaka S, Hirai F.

Intern Med 59（15）:1855-1860,2020

3.Hepatitis B virus core-related antigen is useful for surveillance of hepatocellular carcinoma recurrence in a patient with occult hepatitis B virus infection: Case report.

Yokoyama K, Yamauchi E, Uchida Y, Kitaguchi T, Fukuda H, Yamauchi R, Tsuchiya N, Umeda K, Takata K, Tanaka T, Inomata S, Morihara D, Takeyama Y, Shakado S, Sakisaka S, Hirai F.

Clinical Case Reports 8(12):3031-3036,2020

4.Hepatitis B Virus Reactivation after Receiving Cancer Chemotherapy under Administration of Leuprorelin Acetate.

Yamauchi R, Takeyama Y, Takata K, Fukunaga A, Sakurai K, Tanaka T, Fukuda H, Fukuda S, Kunimoto H, Umeda K, Morihara D, Yokoyama K, Irie M, Shakado S, Sakisaka S and Hirai F.

Intern Med 59:1163-1166, 2020

5.Horizontal Transmission of Hepatitis B Virus Genotype C Among Members of a Wrestling Club in Japan

Takata K, Yamauchi E, Shakado S, Uehara Y, Fukuda H, Yamauchi R, Tsuchiya N, Kunimoto H, Tanaka T, Yokoyama K, Morihara D, Takeyama Y, Sakisaka S, Hirai F.

Am J Case Rep ;21:e925044. doi: 10.12659/AJCR.9250442020 Aug 31

6.Mass-forming adenomyomatosis in extrahepatic bile duct

Ishida Y, Okabe Y, Hisaka T, Naito Y, Torimura T.

Gastrointestinal Endoscopy 93(2):522-524,2020

7.巨大総胆管結石に併発した膵十二指腸動脈瘤破裂による胆道出血の１救命例

安元真希子、荒木俊博、岡部義信、新関　敬、城野智毅、石田祐介、牛島知之、阪上尊彦、鶴田　修、鳥村拓司

日本消化器病学会雑誌 117(1):92-98. 2020

8.A case of episodic angioedema with eosinophilia in an elderly woman with primary biliary cholangitis

Iwashita H, Shakado S, Yasuda H, Tanabe T, Yamaguchi M, Irie M, Hirai F.

Clin J Gastroenterol doi:10.1007/s12328-021-01375-w. Online ahead of print.2021 Mar 10.

9.Novel Endoscopic Therapy for Gastric Varices Using Direct Forward-Viewing Endoscopic Ultrasonography

Yokoyama K, Miyayama T, Uchida Y, Fukuda H, Yamauchi R, Tsuchiya N, Umeda K, Takata K, Tanaka T, Inomata S, Morihara D, Takeyama Y, Shakado S, Sakisaka S, Hirai F.

Case Rep Gastroenterol. 15(1):28-34. 2021

1.クローン病小腸狭窄病変に対するバルーン拡張術

平井郁仁

INTESTINE 24(3):177-184, 2020

2.クローン病治療の最先端

平井郁仁

Medical Science Digest 46(7):10(382)-14(386), 2020

3.潰瘍性大腸炎の診断はどのように行い、治療開始するのか？

松岡　賢、平井郁仁

Medical Practice 37(12):1848-1854,2020

4.炎症性腸疾患の診断：臨床医が診断時に注意すべきポイントとは？診断に迷ったらどうする？新規modalityをどう使いこなす？

今給黎 宗、石橋英樹、平井郁仁

Pharma Medica 38（11）:31-35,2020

5.COVID-19パンデミック状況下における炎症性腸疾患の管理に関する専門家の意見JAPAN IBD COVID-19 TASKFORCE 厚生労働科学研究費補助金(難治性疾患政策研究事業)難治性炎症性腸管障害に関する調査研究班

仲瀬裕志、松本主之、松浦 稔、飯島英樹、松岡克善、大宮直木、石原俊治、平井郁仁、我妻康平、横山佳浩、久松 理一

日本消化管学会雑誌 4（1）:15－24,2020

6.肝がんに対する肝移植を考慮するタイミング-患者説明のタイミング

竹山康章、向坂彰太郎、田中榮司、市田隆文、裵成寛

肝癌診療マニュアル　第4版 171-173, 2020

7.炎症性腸疾患のモニタリングにおける大腸内視鏡の意義と実際

平井郁仁、久能宣昭、阿部光市

日本消化器病学会雑誌 118(3):203-211, 2021

1.高齢者がん医療Q＆A 総論 第１章　高齢者がんの特徴と評価　3.高齢者でがんを疑ったときの診断的アプローチ・病期決定のための検査　（２）内視鏡検査 Q1.高齢がん患者に対する内視鏡検査を実施するにあたり、その適応・条件は何か？Q2.高齢者がん患者の内視鏡検査の実施にあたって、その留意点は？Q2-1.内視鏡検査にあたって、高齢者の身体的変化に対する留意点は？Q2-2.内視鏡検査にあたって、定期的に服用している抗血栓薬はどうすればいいのか？Q2-3.上部消化管内視鏡検査に伴う偶発症に対する対策は？Q2-4.下部消化管内視鏡検査に伴う偶発症に対する対策は？

石橋英樹(分担）

日本がんサポーティブケア学会 / 厚生労働科学研究費補助金 がん対策推進総合研究事業 「高齢者がん診療指針策定に必要な基盤整備に関する研究」/ 高齢者がん医療協議会(コンソーシアム) pp.25-34,2020

2.高齢者がん医療Q＆A 総論 第6章　低侵襲治療（IVRと内視鏡治療）総論　2.内視鏡治療 Q1. 内視鏡治療に年齢制限はあるか？Q2.高齢者の早期消化管癌に対する内視鏡治療の適応／条件は何か？Q3.高齢者における内視鏡治療でとくに注意すべきことは何か？

船越禎広(分担）

日本がんサポーティブケア学会 / 厚生労働科学研究費補助金 がん対策推進総合研究事業 「高齢者がん診療指針策定に必要な基盤整備に関する研究」/ 高齢者がん医療協議会(コンソーシアム) pp.147-156,2020

1.Safety and efficacy of cold polypectomy compared to endoscopic mucosal resection and hot biopsy polypectomy.

Iwashita H, Takedatsu H, Murao H, Funakoshi S, Kuniki Y, Matsuoka S, Tsukamoto S, Yamaguchi M, Shakado S, Kabemura T, Sakisaka S.

Scand J Gastroenterol 54(5):678-683, 2019

2.IL28B Gene Polymorphism Is Correlated with Changes in Low-density Lipoprotein Cholesterol Levels after Clearance of Hepatitis C Virus Using Direct-acting Antiviral Treatment.

Morihara D, Ko YL, Shibata K, Yamauchi R, Fukuda H, Tsuchiya N, Fukunaga A, Kunimoto H, Iwashita H, Takata K, Tanaka T, Sakurai K, Inomata S, Yokoyama K, Nishizawa S, Takeyama Y, Irie M, Shakado S, Sohda T, Sakisaka S.

J Gastroenterol Hepatol 34(11):2019-2027, 2019

3.Endoscopic and clinicopathological characteristics of gastrointestinal adult T-cell leukemia/lymphoma.

Ishibashi H, Nimura S, Kayashima Y, Takamatsu Y, Iwasaki H, Harada N, Momosaki S, Takedatsu H, Sakisaka S, Takeshita M.

J　Gastrointest Onco 10(4):723-733, 2019

4.Development of a C1q-immobilized(Cim) assay to measure total antibodies to infliximab and its clinical relevance in patients with inflammatory bowel disease.

Yoshimura N, Yokoyama Y, Sako M, Aoyama N, Hirai F, Sawada K, Kashiwagi N, Suzuki Y.

Cytokine 120:54-61,2019

5.Measurement of prostaglandin metabolites is useful in diagnosis of small bowel ulcerations.

Matsuno Y, Umeno J, Esaki M, Hirakawa Y,Fuyuno Y, Okamoto Y, Hirano A, Yasukawa S, Hirai F, Matsui T, Hosomi S, Watanabe K, Hosoe N, Ogata H, Hisamatsu T,Yanai S, Kochi S, Kurahara K, Yao T, Torisu T, Kitazono T, Matsumoto T

World J　Gastroenterol 25(14):1753-1763,2019

6.Withdrawal of thiopurines in Crohn’s disease treated with scheduled adalimumab maintenacce: a prospective randomised clinical trial (DIAMOND2)

Hisamatsu T, Kato S, Kunisaki R, Matsuura M, Nagahori M, Motoya S, Esaki M, Fukata N, Inoue S, Sugaya T, Sakuraba H, Hirai F, Watanabe K, Kanai T, Naganuma M, Nakase H, Suzuki Y, Watanabe M, Hibi T, Nojima M, Matsumoto T, DIAMOND2 Study Group

J Gastroenterol 54(10):860-870, 2019

7.Efficacy of enteral nutrition in patients with Crohn’s disease on maintenance anti-TNF-alpha antibody therapy: a meta-analysis

Hirai F, Takeda T, Takada Y, Kishi M, Beppu T, Takatsu N, Miyaoka M, Hisabe T, Yao K, Ueki T.

Journal of Gastroenterology 55（2）,133-141,2020

8.Liver transplantation in Japan: Registry by the Japanese Liver Transplantation Society.

Umeshita K, Inomata Y, Furukawa H, Kasahara M, Kawasaki S, Kobayashi E, Kokudo N, Sakisaka S, Shimada M, Tanaka E.

Hepatology Research 49（9）:964-980, 2019

9.Changes in the Serum Hepcidin-to-ferritin Ratio with Erythroferrone after Hepatitis C Virus Eradication Using Direct-acting Antiviral Agents.

Inomata S, Anan A, Yamauchi E, Yamauchi R, Kunimoto H, Takata K, Tanaka T, Yokoyama K, Morihara D, Takeyama Y, Irie M, Shakado S, Sohda T, Sakisaka S.

Internal Medicine 58:2915-2922,2019

10.Predictors of hepatocellular carcinoma recurrence associated with the use of direct-acting antiviral agent therapy for hepatitis C virus after curative treatment: A prospective multicenter cohort study.

Nakano M, Koga H, Ide T, Kuromatsu R, Hashimoto S, Yatsuhashi H, Seike M, Higuchi N, Nakamuta M, Shakad S, Sakisaka S, Miuma S, Nakao K, Yoshimura Y, Ssasaki Y, Oeda S, Eguchi Y, Honma Y, Harada M, Nagata K, Mawatari S, Ido A, Maeshiro T, Matsumoto S, Takami Y, Sohda T, Torimura T.

Cancer Medicine 8:2646-2653, 2019

1.Hepatobiliary and Pancreatic: An intraperitoneal gallstone due to gallbladder perforation.

Takata K, Matsumoto K, Hirai F.

J Gastroenterol Hepatol. 　2020 ;35(3):362.

2.A Case of Gastric Adenocarcinoma of Fundic Gland Mucosa Type Arising from Helicobacter pylori-Negative Mucosa

Ishibashi H, Nimura S, Tanabe T, Kayashima Y, Matsumoto K, Yamaguchi M, Imakiire S, Shirotani T, Matsuoka H, Yasuda H, Sakisaka H, Matsuoka S, Kunou N, Abe K, Funakoshi S, Takedatsu H, Hirai F.

福岡大学医学紀要 47（1）,87-92,2020

1.潰瘍性大腸炎の診断基準　Japanese Diagnostic Criteria of Ulcerative Colitis

平井郁仁

臨牀消化器内科　 34(7):774-778, 2019

2.逆行性回腸造影の手技の実際　　福岡大学筑紫病院式小腸造影

平井郁仁、頼岡　誠、八尾恒良

胃と腸 54（9）:1295-1298, 2019

3.小腸の非腫瘍性疾患　非特異性多発性小腸潰瘍症／CEAS

冬野雄太、梅野淳嗣、平野敦士、保利喜史、藤原美奈子、前畠裕司、小林広幸、河内修司、蔵原晃一、安川重義、平井郁仁、鳥巣剛弘、江﨑幹宏

胃と腸 54（4）:485-495, 2019

4.小腸の非腫瘍性疾患　セリアック病

武田輝之、平井郁仁、高津典孝、岸　昌廣、別府剛志、久部高司、宮岡正喜、八尾建史、金城　健、太田敦子、田邉　寛、原岡誠司、岩下明德、長浜　孝、植木敏晴

胃と腸 54（4）:515-525, 2019

5.Crohn病　病型分類

髙津典孝、平井郁仁

胃と腸　増刊号 54（5）増刊号:720, 2019

6.Crohn病　モントリオール分類

岸　昌廣、平井郁仁

胃と腸　増刊号 54（5）増刊号:722-723, 2019

7.下痢をきたす疾患の診療　炎症性腸疾患

平井郁仁

臨牀と研究 96（11）:6-13, 2019

8.炎症性腸疾患の内科治療

平井郁仁

消化器外科 42（12）:1645-1652, 2019

9.ベドリズマブの作用機序と臨床成績

久能宣昭、平井郁仁

IBD　Research 13（4）,217-222(29-34)，2019

10.消化器疾患の時代的変遷と最近の話題

平井郁仁

臨牀と研究 97(3), 103-108, 2020

1.§6-16　門脈圧亢進症

横山圭二、向坂彰太郎

1361　専門家による私の治療2019-20年度版：日本医事新報社 2019

2.基礎13（Q013 白血球除去療法はなぜIBDに有効なのか？）、基礎19（Q019 CDの感受性遺伝子であるTL1A(TNFSF15)はIBDにどのように関与するか？）、基礎20（Q020 sgp130-FcによるIL-6 trans-signalingの制御はIBDの新たな治療法となり得るか？）、基礎21（Q021 STAT3をターゲットとしたJAK/STATシグナル伝達調節はIBDに関与するか？）、基礎29（Q029 IBDを制御できる腸内細菌は存在するか？）　解説

竹田津英稔

これだけは読んでおきたい！　消化器医のための重要論文240篇 ＜炎症性腸疾患編＞：シービーアール 2019

1.Diagnostic and clinical role of serum proteinase 3 antineutrophil cytoplasmic antibodies in inflammatory bowel disease.

Takedatsu, H., Mitsuyama, K.,Fukunaga, S., Yoshioka, S, Yamauchi, R, Mori, A., Yamasaki, H., Kuwaki, K., Sakisaka, H., Sakisaka, S., Torimura, T.

J Gastroenterol Hepatol.　33:1603-1607,2018

2.Factors Attenuating Zinc Deficiency Improvement in Direct-Acting Antiviral Agent-Treated Chronic Hepatitis C Virus Infection.

Ko YL, Morihara D, Shibata K, Yamauchi R, Fukuda H, Kunimoto H, Takata K, Tanaka T, Inomata S, Yokoyama K, Takeyama Y, Shakado S, Sakisaka S.

Nutrients.　 2;10(11). pii: E1620. ,2018

3.Endoscopic treatment or balloon-occluded retrograde transvenous obliteration is safe for patients with esophageal/gastric varices in Child-Pugh class C end-stage liver cirrhosis.

Yokoyama K, Yamauchi R, Shibata K, Fukuda H, Kunimoto H, Takata K, Tanaka T, Inomata S, Morihara D, Takeyama Y, Shakado S, Sakisaka S.

Clin Mol Hepatol.　doi: 10.3350/cmh.2018.0039. [Epub ahead of print]

4.POGLUT1, the putative effector gene driven by rs2293370 in primary biliary cholangitis susceptibility locus chromosome 3q13.33.

Hitomi Y, Ueno K, Kawai Y, Nishida N, Kojima K, Kawashima M, Aiba Y, Nakamura H, Kouno H, Kouno H, Ohta H, Sugi K, Nikami T, Yamashita T, Katsushima S, Komeda T, Ario K, Naganuma A, Shimada M, Hirashima N, Yoshizawa K, Makita F, Furuta K, Kikuchi M, Naeshiro N, Takahashi H, Mano Y, Yamashita H, Matsushita K, Tsunematsu S, Yabuuchi I, Nishimura H, Shimada Y, Yamauchi K, Komatsu T, Sugimoto R, Sakai H, Mita E, Koda M, Nakamura Y, Kamitsukasa H, Sato T, Nakamuta M, Masaki N, Takikawa H, Tanaka A, Ohira H, Zeniya M, Abe M, Kaneko S, Honda M, Arai K, Arinaga-Hino T, Hashimoto E, Taniai M, Umemura T, Joshita S, Nakao K, Ichikawa T, Shibata H, Takaki A, Yamagiwa S, Seike M, Sakisaka S, Takeyama Y, Harada M, Senju M, Yokosuka O, Kanda T, Ueno Y, Ebinuma H, Himoto T, Murata K, Shimoda S, Nagaoka S, Abiru S, Komori A, Migita K, Ito M, Yatsuhashi H, Maehara Y, Uemoto S, Kokudo N, Nagasaki M, Tokunaga K, Nakamura M.

SCIENTIFIC REPORTS　14;9(1):102.,2019

5.Analysis of 307 cases with drug-induced liver injury between2010 and 2018 in Japan

Aiso M, Takikawa H,Tsuji K,Kagawa T,Watanabe M,Tanaka , Sato K,Sakisaka S , Hiasa Y, Takei Y, Ohira H, Ayada M,Hashimoto E,Kaneko S, Ueno Y ,Ohmoto K,Takaki A,Torimura T,Matsuzaki Y,Tajiri K,Yoneda M, Ito T,Kato N,Ikejima K,Mochida S, Yasuda H, Sakamoto N

Hepatology Research　49：105-110, 2019

6.Daikenchuto (Da-Jian-Zhong-Tang) ameliorates intestinal fibrosis by activating myofibroblast transient receptor potential ankyrin 1 channel.

Hiraishi K, Kurahara LH, Sumiyoshi M, Hu YP, Koga K, Onitsuka M, Kojima D, Yue L, Takedatsu H, Jian YW, Inoue R.

World J Gastroenterol.　21;24(35):4036-4053. , 2018

7.Endoscopic analysis of colorectal serrated lesions with cancer.

Nagata S, Mitsuyama K, Kawano H, Noda T, Maeyama Y, Mukasa M, Takedatsu H, Yoshioka S, Kuwaki K, Akiba J, Tsuruta O, Torimura T.

Oncol Lett.　15(6):8655-8662.2018

8.Direct-acting antiviral agents do not increase the incidence of hepatocellular carcinoma development: a prospective, multicenter study

Ide T, Koga H, Nakano M, Hashimoto S, Yatsuhashi H, Higuchi N, Nakamuta M, Oeda S, Eguch Y, Shakado S, Sakisaka S, Yoshimaru Y, Sasaki Y, Honma Y, Harada M, Seike M, Maeshiro T, Miuma S, Nakao K, Mawatari S, Ido A, Nagata K, Matsumoto S, Takami Y,Sohda T,Tatsuyuki Kakuma T,Torimura T

Hepatology International　https://doi.org/10.1007/s12072-019-09939-2

9.改訂自己免疫性肝炎・原発性胆汁性胆管炎診療ガイドライン

田中篤、大平弘正、高橋敦史、小森敦正、阿部雅則、姜　貞憲、小池和彦、鈴木義之、高木章乃夫、有永照子、鳥村拓司、中本伸宏、原田憲一、十河剛、乾あやの、藤澤知雄、吉澤要、玄田拓哉、銭谷幹男、下田慎治、竹山康章、向坂彰太郎、谷合麻紀子、橋本悦子、中村稔、浪崎正、吉治仁志、本多彰、松崎靖司、廣原淳子、山際訓、滝川一

肝臓　59(4),211-216,2018

1.Fitz-Hugh-Curtis syndrome in a man positive for Chlamydia trachomatis.

Takata K, Fukuda H, Umeda K, Yamauchi R, Fukuda S, Kunimoto H, Tanaka T, Yokoyama K, Morihara D, Takeyama Y, Irie M, Shakado S, Sakisaka S.

Clin J Gastroenterol.　11(4):338-342,2018

2.Autoimmune Hepatitis with Concomitant Idiopathic Thrombocytopenic Purpura Diagnosed by Transjungular Liver Biopsy

Fukuda H,Takata K,Kitaguchi T,Yamauchi R,Kunimoto H,Tanaka T,Yokoyama K,Morihara D,Takeyama Y,Shakado S,Mogi A,Kora S,Koga K,Takeshita M,Yoshimitsu K,Sakisaka S

Case report in hepatology　doi.org/10.1155/2018/5305691

3.Hepatic Pseudolymphoma with an Occult Hepatitis B Virus Infection

Kunimoto H, Morihara D, Nakane S,Tanaka T, Yokoyama K, Anan A, Takeyama Y, Irie M, Shakado S, Noritomi T, Takeshita M,Yoshimitsu K, Sakisaka S

Internal Medicine　57: 223-230, 2018

4.Magnetic resonance cholangiopancreatography for afferent loop syndrome

Takata K, Anan A, Umeda K, Sakisaka S

Clinical Case Reports　7:591-592,2019

5.Hepatocellular carcinoma arising in a noncirrhotic liver with secondary hemochromatosis.

Yamauchi R, Takata K, Shinagawa Y, Tanaka T, Fukuda H, Fukuda S, Kunimoto H, Umeda K, Morihara D, Yokoyama K, Takeyama Y, Irie M, Shakado S, Mizoguchi M, Hisano S, Yoshimitsu K and Sakisaka S

Internal Medicine　58(5):661-665,2019

6.胃腎シャントが自然退縮した肝細胞癌門脈浸潤合併胃静脈瘤の１例

山内　涼、横山圭二、福田祥、田中　崇、入江　真、向坂彰太郎

日本門脈圧亢進症学会雑誌　24(2),154-160,2018

7.十二指腸下行脚に狭窄を来したmonomorphic epitheliotropic intestinal T-cell lymphomaの1例

石橋英樹、二村　聡、萱嶋善行、久能宣昭、竹田津英稔、高松　泰、竹下盛重、向坂彰太郎

胃と腸　53(12)1684-1692,2018

1.IL-5と消化管疾患

阿部光市、竹田津英稔

消化器病学サイエンス　2(4);39(203)-42(206),2018

1.原発性硬化性胆管炎

向坂彰太郎

今日の治療指針　542-543,2018

2.炎症性メディエーター・サイトカインの関与

竹田津英稔、光山慶一

日本臨牀　炎症性腸疾患（第2版）　76巻増刊号3（通巻1140号）87-93,2018

1.Confounding effects of microbiome on the susceptibility of TNFSF15 to Crohn’s disease in the Ryukyu Islands.

Nakagome S, Chinen H, Iraha A,Hokama A, Takeyama Y, Sakisaka S,Matsui T, Kidd JR, Kidd KK, Said HS,Suda W, Morita H, Hattori M,Hanihara T, Kimura R, Ishida H, Fujita J,Kinjo F, Mano S, Oota H

Hum Genet, 136, 387-397, 2017

2.Survival in patients with Child-Pugh class C cirrhosis: analysisof the liver transplant registry inJapan

Genda T, Ichida T, Sakisaka S,Tanaka E, Mochida S, Ueno Y, Inui A,Egawa H, Umeshita K, Furukawa H,Kawasaki S, Inomata Y

Hepatology Research, 47, 1155-1164, 2017

3.Genome-wide association studiesidentify PRKCB as a novel geneticsusceptibility locus for primarybiliary cholangitis in the Japanesepopulation

Kawashima M, Hitomi Y, Aiba Y,Nishida N, Kojima K, Kawai Y,Nakamura H, Tanaka A, Zeniya M,Hashimoto E, Ohira H, Yamamoto K,Abe M, Nakao K, Yamagiwa S,Kaneko S, Honda M, Umemura T,Ichida T, Seike M, Sakisaka S,Harada M, Yokosuka O, Ueno Y,Senju M, Kanda T, Shibata H,Himoto T, Murata K, Miyake Y,Ebinuma H, Taniai M, Joshita S,Nikami T,Ota H, Kouno H,Kouno H, Nakamuta M, Fukushima N,Kohjima M, Komatsu T, Komeda T,Ohara Y, Muro T, Yamashita T,Yoshizawa K, Nakamura Y, Shimada M,Hirashima N, Sugi K, Ario K,Takesaki E, Naganuma A, Mano H,Yamashita H, Matsushita K,Yamauchi K, Makita F, Nishimura H,Furuta K, Takahashi N, Kikuchi M,Masaki N, Tanaka T, Tamura S,Mori A, Yagi S, Shirabe K, Komori A,Migita K, Ito M, Nagaoka S, Abiru S,Yatsuhashi H, Yasunami M, Shimoda S,Harada K, Egawa H, Maehara Y,Uemoto S, Kokudo N, Takikawa H,Ishibashi H, Chayama K, Mizokami M,Nagasaki M, Tokunaga K andNakamura M

Human Molecular Genetics, 26(3), 650-659, 2017

4.Combinational use of hepatitis Bviral antigens predicts responsesto nucleos(t)ide analogue/peginterferonsequential therapy.

Matsumoto A, Nishiguchi S,Enomoto H, Jong-Hon Kang, Tanaka Y,Shinkai N, Kurosaki M, Enomoto M,Kanda T, Yokosuka O, Yatsuhashi H,Nagaoka S, Okuse C, Kagawa T,Mine T, Takaguchi K, Saito S, Hino K,Ikeda F, Sakisaka S, Morihara D,Miyase S, Tsuge M, Chayama K,Hiramatsu N, Suzuki Y, Murata K,Tanaka E

J Gastroenterol. DOI 10.1007/s00535-017-1360-z

5.The Rate of Referral of HepatitisVirus Carriers to Hepatologistsand the Factors Contributing toReferral

Takata K, Anan A, Morihara D,Yotsumoto K, Sakurai K, Fukunaga A,Tanaka T, Yokoyama K, Takeyama Y,Irie M, Shakado S, Sohda T, Sakisaka S

Internal Medicine, 56(15),1943-148,2017

6.Increased hepatic ABCA1transporter is associated withhypercholesterolemia in acholestatic rat model and primarybiliary cholangitis patients

Takeyama Y, Uehara Y, Anan A,Morihara D, Yokoyama K, Takata K,Tanaka T, Irie M, Iwata K, Shakado S,Sohda T, Sakisaka S

Medical molecularmorphology, 50:227-237,2017

7.Stereomicroscopic features ofcolitis-associated tumors in mice:Evaluation of pit pattern.

Yamauchi R, Kominato K, Mitsuyama K,Takedatsu H, Yoshioka S, Kuwaki K,Yamasaki H, Fukunaga S, Mori A,Akiba J, Tsuruta O, Torimura T.

Oncology Letters. 2017 Sep;14(3):3675-3682

8.Study to determine guidelines forpediatric colonoscopy.

Yoshioka S, Takedatsu H, Fukunaga S,Kuwaki K, Yamasaki H, Yamauchi R,Mori A, Kawano H, Yanagi T,Mizuochi T, Ushijima K, Mitsuyama K,Tsuruta O, Torimura T.

World Journal ofGastroenterology. 2017 Aug21;23(31):5773-5779.

1.Non-response to daclatasvir and asunaprevir therapy inpatients co-infected with hepatitis C virus genotypes 1 and 2

Sohda T, Yamauchi E, Anan A, Yokoyama K, Fukunaga A, Yamauchi R, Fukuda S, Takata K, Tanaka T, Hanano T, Kitamura Y, Morihara D, Takeyama Y, Irie M, Shakado S and Sakisaka S

Hepatology Research, 2017 Mar47(4):364-367

2.Disappearance of multiple hyperechoic liver nodules in sporadic porphyria cutanea tarda after treatment with ledipasvir/ sofosbuvir for hepatitis C.

Takata K, Shakado S, Sakamoto K, Fukuda H, Yamauchi R, Fukuda S, Kunimoto H, Umeda K, Tanaka T, Yokoyama K, Morihara D, Takeyama Y, Irie M, Sakisaka S.

Clinical Journal of Gastroenterology, 2017,10(5):459-463

3.Hepatic Hodgkin Iymphoma with delayed enhancement on CT and MRI

Higuma Y, Yamauchi R, Fujimitsu R, Sakamoto K, Shinagawa Y, Morita A, Urakawa H, Takeshita M, Yoshimitsu K

Radiology case reports, 2017 Mar; 12(1): 45-49.

4.A case of porphyria cutanea tarda of the liver exhibiting multifocal macrovesicular steatosis in the background of microvesicular steatosis, probably caused by uneven iron accumulation.

Nishiyama M, Sakamoto K, Shinagawa Y, Morita A, Urakawa H, Fujimitsu R, Shakado S, Hamada Y, Yoshimitsu K

Abdominal radiology (New York), 2017Jul;42(7):1813- 1818.

5.Gastric Metastasis from Breast Cancer Resembling Primary Gastric Cancer:A Case Report

Ishibashi H, Kayashima Y, Nimura S, Sakisaka S

福岡大学医学紀要, 44(1),29-33,2017

6.術前に確定診断に至らなかった隆起 型胃MALTリンパ腫の1例

石橋英樹、二村　聡、冨岡禎隆、 中山景一郎、頼岡　誠、田中　隆

胃と腸, 52(10):1355-1360,2017

7.A Rare Case of Ulcerative Colitis with Neurofibromatosis Type 1.

Fukunaga S, Takedatsu H, Mitsuyama K, Torimura T

Kurume Medical Journal., 2017 Jul 3

8.Duodenal Metastases from Lung Carcinoma.

Mori A, Yamasaki H, Takedatsu H, Mitsuyama K.

Internal Medicine, 2017;56(5):573-574

9.An unusual cause of colonic stricture with polyps.

Fukunaga S, Takedatsu H, Muta H, Mitsuyama K, Torimura T.

Gut, 2017 Aug;66(8):1495.

1.【図説「胃と腸」所見用語集2017】画像所見[腸] 腸管壁内ガス像(intramural gas appearance)

萱嶋善行、藏原晃一

胃と腸, 52(5), 645, 2017

2.【大腸スクリーニングの現状と将来展望】 美麗な二重造影　私のコツすべて教えます　注腸X線造影検査

藏原晃一、川崎啓祐、浦岡尚平、八板弘樹、平田　敬、萱嶋善行、吉田雄一朗、森崎晋史、佐藤香織、末場　瞳、小林広幸

胃と腸, 52(9), 1128-1135, 2017

1.Bile Acids and Viral Hepatitis and Hepatocellular Carcinoma

Takeyama Y, Sakisaka S

Bile Acids in Gastroenterology Basic and Clinical, DOI 10.1007/978-4- 431-56062-3_11

2.原発性胆汁性胆管炎

向坂彰太郎

内科学（第11版）, 1095-1097, 2017.3

3.門脈圧亢進症

入江　真、向坂彰太郎

1336専門家による私の治療, 474-476,2017.7

4.原発性胆汁性胆管炎(PBC)診療ガイド ライン（2017年）
厚生労働省難治性疾患政策研究事業 「難治性の肝・胆道疾患に関する調 査研究」班

向坂彰太郎、竹山康章

原発性胆汁性胆管炎（PBC） 診療ガイドライン（2017年）, 1-56,2017.3

1.Long-Term Outcomes of Hepatitis-C-Infected Patients Achieving a Sustained Virological Response and Undergoing Radical Treatment for Hepatocellular Carcinoma

Kunimoto　H,Ikeda K,Sorin Y,Fujiyama S,Kawamura Y,Kobayashi M,Sezaki H,Hosaka T, Akuta N,Saitoh S,Suzuki F,Suzuki Y, Arase Y,Kumada H

Oncology, 90(3)167-175,2016

2.Three-Dimensional Imaging Using Contrast-Enhanced and Three-Dimensional Ultrasound Techniques in the Ablative Zone Treated with a Multipolar Radiofrequency Ablation System for Hepatocellular Carcinoma

Tanaka T, Ikeda K,Sorin Y, Fukushima T,Kawamura Y, Kobayashi M, Kumada H

Oncology, 90(4):255-260,2016

3.Reduced Glutathione suppresses Oxidative Stress in Nonalcoholic Fatty Liver Disease.

Irie M,Sohda T,Anan A,Fukunaga A,Takata K,Tanaka T,Yokoyama K,Morihara D,Takeyama Y,Shakado S,Sakisaka S

Euroasian Journal of Hepato-Gastroenterology, 6(1):13-18,2016

4.High Expression of Intestinal Homing Receptor CD103 in Adult T-Cell Leukemia/Lymphoma ,Similar to 2 Other CD8+ T-Cell Lymphomas

Ishibashi H,Nimura S,Ishitsuka K,Mihashi Y,Mizoguchi M,Nakamura S,Okamura S,Momosaki S,Aoyagi K,Sakisaka S,Takeshita M

The American Journal of Surgical Pathology, 40(4),462-470,2016

5.Advanced endoscopic features of ulcerative colitis-associated neoplasias: Quantification of autofluorescence imaging

Yoshioka S, Mitsuyama K, Takedatsu H, Kuwaki K, Yamauchi R, Yamasaki H, Fukunaga S ,Akiba J ,Kinugasa T, Akagi Y, Tsuruta O,Torimura T

International Journal of ?Oncology, 48:551-8,2016

6.A longitudinal study of FDG-PET in Crohn disease patients receiving granulocyte/monocyte apheresis therapy

Kuwaki K, Mitsuyama K, Kaida H, Takedatsu H, Yoshioka S, Yamasaki H, Yamauchi R, Fukunaga S, ?Abe T, Tsuruta O, Torimura T

Cytotherapy, 18:291-9,2016

7.Increased levels of circulating adrenomedullin following treatment with TU-100 in patients with Crohn’s disease

Kominato K,Yamasaki H, Mitsuyama K,Takedatsu H,Yoshioka S,Kuwaki K,Kobayashi T,Yamauchi R,Fukunaga S,Tsuruta O,Torimura T

Molecular Medicine Reports, Sep;14(3):2264-8,2016

8.Confounding effects of microbiome on the susceptibility of TNFSF15 to Crohn’s disease in the Ryukyu Islands.

Nakagome S, Chinen H, Iraha A, Hokama A, Takeyama Y, Sakisaka S, Matsui T, Kidd JR, Kidd KK, Said HS, Suda W, Morita H, Hattori M, Hanihara T, Kimura R, Ishida H, Fujita J, Kinjo F, Mano S, Oota H

Hum Genet, 136, 387-397, 2017

1.A Probable Case of Burn-out NASH Caused by Panhypopituitarism Secondary to Craniopharyngioma

Terawaki Y, Murase K,Motonaga R, Tanabe M, Nomiyama T, Shakado S, Mizoguchi M, Sakisaka S , Yanase T

Fukuoka Acta Medica, 107(3):53-61,2016

2.Endoscopic Disappearance of a Metastatic Colon Tumor from Primary Lung Cancer after Chemotherapy : A Case Report

Ishibashi H,Nimura S,Aoyagi K, Tashiro N,Tsukamoto S,Watanabe T ,Tomioka Y,Watanabe K,Sakisaka S

福岡大学医学紀要, 43(2),65-70,2016

3.Multiple lesions of gastrointestinal tract invasion by monomorphic epitheliotropic intestinal T-cell lymphoma, accompanied by duodenal and intestinal enteropathy-like lesions and microscopic lymphocytic proctocolitis: a case series

Ishibashi H, Nimura S,Kayashima Y,Takamatsu Y,Aoyagi K,Harada N, Kadowaki M, Kamio T,Sakisaka S, Takeshita M

Diagnostic Pathology, 25:11(1),2016

4.MR Imaging of a Methotrexate-associated Diffuse Large B-cell Lymphoma in the Liver that Regressed without Treatment

Morikawa S,Morita A,Fujimitsu R,Kuroki Y,Urakawa H,Shinagawa Y,Morihara D,Aoki M,Yoshimitsu K

Magnetic Resonance in Medical Sciences, 15(3),249-250,2016

5.Efficacy of peritoneovenous shunt for treating tolvaptan-resistant refractory ascites in a cirrhotic patient with portal vein thrombosis:A case report

Shigeto K,kawaguchi T,Niizeki T, Kunitake Y, Takedatsu H,Tonan T,Fujimoto K, Tanaka M, Abe T,Naito H,Torimura H

Oncology Letters, May;11(5):3205-3209,2016

6.Gastric Metastasis from Breast Cancer Resembling Primary Gastric Cancer:A Case Report

Ishibashi H,Kayashima Y, Nimura S, Sakisaka S

福岡大学医学紀要, 44(1),29-33,2017

7.【狭窄を来す小腸疾患の診断】原発性小腸癌

石橋英樹、二村　聡

胃と腸, 51(13),1708-1709,2016

8.消化管病変を合併したvon ?Recklinghausen病

石橋英樹、二村　聡、大石　純、谷村　修、冨岡禎隆、古賀丈二

胃と腸, 51(8),1048-1054,2016

1.Antibody markers in the diagnosis of inflammatory bowel disease

Mitsuyama　K, Niwa M, Takedatsu H, Yamasaki H, Kuwaki K, Yoshioka S, Yamauchi R, Fukunaga S, Torimura T

World Journal of Gastroenterology, 22:1304 -1310,2016

2.胆汁酸研究の進歩と展望－これからのbreakthrough を目指して－
胆汁うっ滞における肝のコレステロール・胆汁酸代謝動態の変化

竹山康章、向坂彰太郎

肝胆膵, 72(5)：785-791,2016

3.リピオドールTACEを先行した肝細胞癌症例に対し治療支援としてCアーム型透視X線装置を併用したマルチポーラRFAの治療経験

田中　崇、阿南　章、高田和英、福田洋美、山内　涼、福田　祥、福永篤志、花野貴幸、平野玄竜、喜多村祐次、横山圭二、森原大輔、竹山康章、入江　真、釈迦堂　敏、早田哲郎、向坂彰太郎

肝臓, 571(4):186-189;2016

1.Intestinal myofibroblast TRC6 channel may contribute to stenotic fibrosis in Croh’n disease.

Kurahara LH,Sumiyoshi M,Aoyagi K,Hiraishi K,Nakagawa M,Hu Y,Inoue R

Inflammatory Bowel Diseases, 21(3),496-506,2015

2.Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imagingas a useful detection method for advanced primary biliary cirrhosis

Takeyama Y,Tsuchiya N, Kunimoto H,Fukunaga A,Sakurai K,Hirano G,Yokoyama K,Morihara D,Anan A, Irie M,Shakado S,Sohda T,Sakisaka S

Hepatology Research, 45:E108-E114,2015

3.Alpha-fetoprotein and des-gamma-carboxy-prothrombin at twenty-four weeks afterferon-based therapy predict hepatocellular carcinoma development

Shakado S,Sakisaka S,Chayama K,Okanoue T, Toyoda J ,Izumi N, Matsumoto A ,Takehara T, Ido A ,Hiasa Y, Yoshioka K,Nomura H,Ueno Y, Seike M,Kumada H

World Journal of Hepatology, 287(27):2757-2764,2015

4.A Hereditary Enteropathy Caused by Mutations in the SLCO2A1 Gene,Encoding a Prostaglandin Transporter

Umeno J,Hisamatsu T,Esaki M,Hirano A,Kubokura N, Asano K,Koichi S, Yanai S,Fuyuno Y, Shimamura K, Hosoe N, Ogata H, Watanabe T,Aoyagi K,Ooki H, Watanabe K, Yasukawa S,Hirai F, Matsui T,Iida M,Yao T,Hibi T, Kosaki K,Kanai T, Kitazono T, Matsumoto T

PLOS Genetics, 11(11):e1005581.doi:10.1371,2015

5.特集：消化管原発悪性リンパ腫　消化管リンパ腫の臨床病理

二村　聡、石塚賢治、石橋英樹、塩飽洋生、木庭郁朗、中屋照雄、蓮池典明

消化器内視鏡, 27(5),749-753,2015

6.Multipolar RFA治療における穿刺位置と焼灼域に関する検討

國本英雄、池田健次、宗林祐史、藤山俊一郎、川村祐介、瀬崎ひとみ、保坂哲也、芥田憲夫、小林正宏、鈴木文孝、鈴木義之、斎藤　聡、荒瀬康司、熊田博光

医学と薬学, 72(9)1523-1527,2015

7.脳卒中急性期患者の経管栄養におけるレモン果汁併用の効果と安全性の検討

山田 由李子, 本多 里美, 緒方 利安, 山本 澄子, 用松 美咲, 竹下 恵美, 青柳 邦彦, 坪井 義夫, 井上 亨

脳卒中, 37(6)452-455,2015

8.Long-Term Outcomes of Hepatitis-C-Infected Patients Achieving a Sustained Virological Response and Undergoing Radical Treatment for Hepatocellular Carcinoma

Kunimoto H,Ikeda K,Sorin Y,Fujiyama S,Kawamura Y,Kobayashi M,Sezaki H,Hosaka T,Akuta N,Saitoh S,Suzuki F,Suzuki Y, Arase Y,Kummada H

Oncology, 90(3)167-175,2016

1.Endoscopic removal of a tablespoon lodged within the duodenum

Watanabe T,Aoyagi K,Tomioka Y,Ishibashi H,Sakisaka S

World Journal of Gastroenterology, 21(16),5096-5098,2015

2.特発性門脈圧亢進症に伴う巨大な脾腎シャントにより慢性糸球体腎炎をきたしたと考えられた1例

横山圭二、平野玄竜、田中　崇、阿南　章、入江　真、向坂彰太郎

日本門脈圧亢進症学会雑誌, 21(1),38-43,2015

3.特集：腸管悪性リンパ腫　Ⅲ　症例　(2)十二指腸下行脚に狭窄をきたしたⅡ型腸管症関連T細胞性リンパ腫(enteropathy-associated T-cell lymphoma)の一例

石橋英樹、竹下盛重、山田　梢、二村　聡、高松　泰

INTESTINE, 19(3), 292-296,2015

4.Colitis mimicking graft-versus-host disease during treatment with the anti-CCR4 monoclonal antibody, mogamulizumab.

Ishitsuka K, Murahashi M, Katsuya H, Mogi A, Masaki M, Kawai C, Goto T, Ishizu M, Ikari Y, Takamatsu Y, Ishibashi H, Nimura S, Takeshita M, Tamura K.

International Journal of Hematology, 102(4):493-7,2015

5.狭窄を来す大腸疾患 診断のプロセスを含めて　症例7

石橋英樹、二村　聡、江口浩一、冨岡禎隆、渡邉　隆、星野誠一郎、向坂彰太郎

胃と腸, 50(10),1304-1307,2015

6.感染巣の抜歯を契機に発症したと考えられるStreptococcus anginosus　による肝腫瘍の１例

岩下英之、松井謙明、塚本真仁、船越禎広、山口真三志、壁村哲平、早田哲郎、向坂彰太郎

日本消化器病学会雑誌, 112(8):1525-1532,2015

7.Upregulation of des-gamma-carboxy-prothrombin after portal vein embolization in a cirrhotic patient with hepatocellular carcinoma.

Sohda T, Iwata K, Anan A, Kunimoto H, Yotsumoto K,Yokoyama K, Morihara D, Takeyama Y, Shakado S, Osame A, Kora S, Ohishi J, Yamauchi Y, Noritomi T, Yoshimitsu K, Yamashita Y, Sakisaka S

Clinical journal of gastroenterology, 8(5):330-4,2015

8.【腸管悪性リンパ腫】症例　Whipple病疑診例に合併した回腸diffuse large B-cell lymphoma

二村 聡, 岩下 明徳, 上杉 憲子, 岩崎 宏, 竹下 盛重, 青柳 邦彦, 藤木 健弘, 倉持 均, 若松 信一

Intestine, 19(3)297-301,2015

1.肝細胞癌に対する肝移植を考慮するタイミング：患者説明のタイミング

竹山康章、菅原寧彦、向坂彰太郎

肝癌診療マニュアル　第3版, 121-123, 2015

2.非腫瘍性疾患　Cronkhite-Canada症候群の胃病変

森下 寿文, 蔵原 晃一, 八板 弘樹, 渡邉 隆, 河内 修司, 長末 智寛, 久能 宣昭, 阿部 洋文, 原田 英, 岩崎 一秀, 大城 由美, 小林 広幸, 江崎 幹宏, 渕上 忠彦

胃と腸, 50(6),806-809,2015

3.DC BeadによるTACE

國本英雄、池田健次

たんじゅうさん, 14(1),12-13,2015

4.主題症例　非腫瘍性疾患：IFP（inflammatory fibroid polyp)

石橋英樹、阿部光市、二村　聡

胃と腸, 50(6), 818-820,2015